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 The mammalian kidney is a complex structure composed of many highly 
differentiated cell types. The spatial distribution of these cells, however, emerges from 
elaboration of an earlier program of epithelial and mesenchymal interactions in which 
a tubular epithelium, the ureteric bud, undergoes successive rounds of branching within 
the metanephric mesenchyme. Signaling through the receptor tyrosine kinase RET is 
required for the normal progression of this developmental program. A complete portrait 
of the transcriptional changes effected by RET activation has emerged through microarray 
profiling. Genetic studies in the mouse have further elucidated the roles of many of these 
downstream genes in mediating particular inductive events, or in directing a cell toward a 
particular differentiation program. Comparatively little is known, however, about the fates 
of Ret-expressing tip cells, themselves, and of the cell-level manipulations required to 
sustain branching of the ureteric bud.
 The research presented in this thesis is an attempt to broach these questions by 
harnessing the growing precision of cell-level, mosaic genetic manipulations. An inducible 
Cre allele under control of the Ret promoter served as a tool to unambiguously confirm that 
Ret-expressing tip cells are multipotent progenitors that give rise to the entirety of the renal 
collecting system. The Ret-expressing tip cells form a self-renewing niche that furthermore 
gives rise to the “trunk” regions of collecting system. As these tip-derived progeny 
differentiate, they are competent to assume both principal and intercalated phenotypes.
 The RetCreERT2 allele, itself a null allele, was used to mosaically ablate Ret within 
the tip domain by crossing to a conditional Ret line. Loss of Ret from a portion of the tip 
cells severely disrupted normal branching, yielding hypomorphic kidneys with dysplastic 
tips. This occurred even upon later stage Ret deletion, suggesting a continued role for Ret 
in maintaining the branching program. Surprisingly, the mosaic loss of Ret from the tip 
domain is more disruptive to the branching program than is mosaic deletion of tip cells 
themselves. In the latter set of experiments, kidney growth was reduced, however, the 
morphology of the tips and of the collecting system remained normal. 
 Mosaic analysis with double markers (MADM) was utilized to follow the fates 
of individual cells that lost Ret activity. This genetic tool proved incredibly powerful, 
revealing that tip cells that lose Ret are near completely excluded from the tip domain. 
Initial results suggest that this sorting behavior might be fairly rapid, which would reject 
the hypothesis that Ret confers a proliferative advantage to the cells. Ret activity might 
instead confer an ability to undergo cell rearrangements or migration-like movements that 
keep a cell positioned at the tip.
 Collectively, these findings augment our appreciation of the Ret-expressing tip 
domain as a special compartment within the branching ureteric bud. Ret plays a continued role 
in maintaining branching past its previously known role in primary ureteric bud formation. 
Finally, the observations made using the MADM technique compel the hypothesis that Ret-
dependent cell rearrangements sculpt and continually refine the branching ureteric bud.
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In addition to filtering metabolic waste products from the blood, the kidneys serve 
the vital functions of maintaining electrolyte and pH homeostasis, and regulating blood 
pressure. Elaboration of primitive renal systems is central to the evolutionary success of 
terrestrial vertebrates. Mammalian kidneys are essentially modular versions of a basic 
filtration unit, the nephron, and human kidneys contain anywhere from 200,000 to 2 
million nephrons (Hoy et al., 2003). The nitrogenous waste products of protein and nucleic 
acid metabolism are filtered, along with a significant portion of the remaining aqueous 
components of the blood, in capsule-bound knots of capillary vessels. Filtrate flows from 
this knot, the glomerulus, due to capillary pressure and into Bowman’s capsule at a rate 
partly determined by the actions of a specialized cell type, podocytes. While the kidneys 
produce a massive amount of initial filtrate, most of the water, proteins and other essential 
molecules are reabsorbed as filtrate passes through the nephron. Individual nephrons plumb 
into an aroboreal collecting system that further concentrates the urine before it drains 
into the bladder via the ureter. The nephrons and collecting system additionally secrete 
molecules into the filtrate to mediate the homeostatic functions of the organ.
As renal function can slowly decline through normal processes of aging and 
environemental exposure, a robust nephron endowment is key to longevity (Brenner and 
Mackenzie, 1997). There’s an even stronger link between reduced nephron number and 
hypertension (Cullen-McEwen et al., 2003; Keller et al., 2003). Coincident with the rise 
of the “diabesity” epidemic, an increasing number of Americans exhibit impaired renal 
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filtration rates (Coresh et al., 2003). As filtration capacity deteriorates, a patient develops 
end-stage renal disease, requiring dialysis or organ transplant (Levey et al., 2003). 
Understanding the developmental biology of the kidney is thus a matter of public health. 
Basic research into kidney morphogenesis can not only establish the normal sequence of 
events required to build a healthy organ, but possibly also reveal in utero therapies for 
individuals at risk of developing low nephron number.
Defects of the kidney and lower urinary tract are also among the most common 
congential aberrations (Airik and Kispert, 2007). Genetic studies in the mouse have 
successfully replicated the etiology of many of these defects, including renal agenesis and 
hypodysplasia; the development of cystic kidneys; and ureteral problems resulting from 
obstructions, or failure to connect to the bladder. Genes that have now been extensively 
studied in murine systems have been implicated in human genetic kidney diseases. Of 
particular relevance to this thesis, mutations in the gene encoding the receptor tyrosine 
kinase Ret are associated with congenital renal defects, including the most severe 
manifestations that lead to perinatal lethality (Jeanpierre et al., 2011; Lantieri et al., 2006; 
Skinner et al., 2008).
To the student of developmental biology, the kidney is compelling in its own right. 
Early growth of the organ proceeds, largely, by branching morphogenesis of a tubular 
epithlium within a mesenchyme. A similar developmental ontology is employed in other 
mammalian organs, including the mammary glands, lungs and salivary glands. As a 
more complete picture of the epistatic hierarchies of gene activity in kidney development 
emerges, a next challenge is to elucidate how this gene activity leads to changes on the 
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cellular level to sculpt a complex, three-dimensional organ.   
Morphological introduction to kidney development
It is difficult to appreciate the architecture of the mature kidney without a solid 
understanding of the organ’s developmental origins. Many of the functional components 
are derived from elaboration and continued differentiation of structures laid down in earlier 
stages of development. Descriptions of these morphogenetic processes, obtained through 
careful embryological observations and ex utero culture studies, predate the genetic era 
(Grobstein, 1953). Like many other organs, the kidney is derived from epithelial and 
mesenchymal components. The separation of these compartments in culture conditions 
revealed the key role of reciprocal inductive interactions (Boyden, 1927; Grobstein, 1956). 
As the genetic dissection of the kidney has progressed over the last thirty years, a more 
refined description of the morphology of kidney development has emerged. Many of the 
findings presented in this morphological outline are thus abstracted from genetic studies 
and it is admittedly difficult to divorce discussion of growth patterns from gene activity. 
The aim of this outline is a brief, but complete, description of the morphological basis of 
kidney development, parts of which will be elaborated in subsequent sections. 
The definitive endoderm and wings of mesoderm are formed during gastrulation, in 
which epiblast cells ingress through the primitive streak between E6.0 and E7.0 (Bellairs, 
1986). While initially on the exterior of the then cup-shaped murine embryo, these germ 
layers come to lie interiorly upon embryonic folding. The kidney is derived from the 
intermediate mesoderm (IM), which lies medially between the more distal lateral plate 
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mesoderm and the paraxial somitogenic mesoderm. The rostral end of the IM lies laterally 
with the anterior-most somites and this compartment extends to the tail end of the embryo. 
Kidney development proceeds in a rostral to caudal sequence. Transient excretory organs, 
the pronephros and mesonephros, actually precede development of the metanephric kidney, 
which is the adult organ in terrestrial vertebrates (Aterman, 1990). In these animals, the 
pronephros is never functional and rapidly degenerates. The mesonephric tubules give 
rise to the epididymis in male embryos and degenerate in females. The pronephros and 
mesonephros persist as adult organs in water-dwelling vertebrates. Fish, for example, expel 
nitrogenous waste through the gills, but depend on the pronephros for osmoregulation. This 
structure consists of a single glomerulus, two nephric tubules and a single collecting tubule 
that connects to the cloaca.
Beginning around E9.0, cells on the dorsal sides of the IM coalesce into ducts 
that elongate in a rostral-caudal manner, known in early stages as the nephric duct (ND) 
and in mature form as the Wolffian ducts (WD) (Cornish and Etkin, 1993). This tubular 
epithelium is a lumenized monolayer of high columnar cells (Chi et al., 2009b). The 
WD extends to the tail end of the embryo and is tightly associated with the remaining 
mesenchyme of the IM, referred to as the nephrogenic cord (NC) at pre-budding stages. 
The very tail end of the WD connects to the primitive urogenital sinus at E9.5 (Obara-
Ishihara et al., 1999; Viana et al., 2007). By E10.0 a portion of the mesenchyme adjacent 
to the midsection of the WD undergoes a mesenchymal to epithelial transition, forming the 
mesonephric tubules. By E10.5 only the caudal-most tubules remain, as the rostral ones 
regress. Cell rearrangements in a portion of the WD slightly rostral to this connection form 
6Figure 1.1 The morphology of kidney development. (A) The kidney is derived from the 
intermediate mesoderm (IM). The nephric duct forms from the dorsal IM (blue) and the nephrogenic 
cord from the remaining ventral IM (green). (B-E) The ND grows in a rostral to caudal sequence as 
an epithelium that secondarily lumenizes. (F-G) By E10.5 the nephric duct has inserted into the 
cloaca and the caudal end of the Wolffian duct forms a pseudostratified epithelium. (H) This region 
become the primary budding site as the UB grows into the adjacent metanephric mesenchyme. (I) 
By E11.5 the primary UB has bifurcated, forming a T-shaped UB. (J) These terminal tips undergo 
at least 8 rounds of subsequent branching that lasts until E15.5. Two additional rounds of branching 
occur between E17.5 and birth. (K-L) The initial arboreal structure formed by branching of the UB 
is remodeled into the collecting system of the mature kidney. Nephrogenesis occurs at the 
periphery of the kidney where the tips reside in the cortex. (M) There is significant growth of the 
kidney following birth, which in the collecting system results in the elongation of collecting tubules 
and the extension of the papilla into the ureter. (Adapted from Costantini and Kopan, 2010)
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a pseudostratified epithelium (Chi et al., 2009b). This pseudostratified region buds into the 
adjacent metanephric mesenchyme (MM) as a tube that swells into an ampulla at the distal 
end; this is the primary ureteric bud (UB).
By E11.5 this ampulla bifurcates forming the “T-shaped” UB. The mesenchyme 
condenses around the UB and remains intimately associated for the remainder of kidney 
development. The stalk region of the UB sticking out of the MM will give rise to the ureter. 
Rearrangements at the caudal end of the nephric duct result in the separation of the ureter 
from the WD. As the primary UB arises rostrally to the tip of the WD, the ND must first 
be fully integrated into the urogenital sinus (UGS), resulting in the vertical displacement 
of the ureter so that it too meets the bladder primordium. This vertical placement is partly 
dependent on apoptosis within the ND. Between E12.0 and E14.0, apoptosis disrupts the 
remaining cellular connections between the ureter and WD, which are laterally displaced 
as the UGS expands. By E14.0 these two tubes are fully separated (Batourina et al., 2002; 
Batourina et al., 2005; Chia et al., 2011; Viana et al., 2007). In females the WD regresses 
and in males it gives rise to the vas deferens (Tanagho, 1981). 
 Growth of the metanephric kidney is exponential from E11.5 to E17.5. The tips 
of the T-shaped UB undergo at least 8 rounds of subsequent rapid branching. By E15.5 
this branching programs slows, though two additional rounds of branching take place by 
birth. The newborn mouse kidney contains approximately 1600 terminal tips (Cebrian et 
al., 2004). Most branching events proceed via bifurcation of tips, though trifid events also 
occasionally occur, particularly in earlier stages of branching. A very low rate of lateral 
budding from non-tip regions of the growing UB may also contribute to the final tip number 
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(Watanabe and Costantini, 2004). The arboreal structure that results from branching of the 
UB ultimately gives rise to the collecting system of the mature kidney, which includes 
the cortical and medullary collecting tubules, calyces and papilla. This process involves 
significant reorganization of the epithelium such that tubules are sheathed together in 
bundles. The top portion of the ureter greatly expands, forming the renal pelvis, and the 
papilla protrudes into the ureter by birth. 
 The nephrons develop at the periphery of the branching collecting system from the 
closely associated cap mesenchyme (CM). This process begins as pretubular aggregates 
of CM-derived cells come to lie under the UB tips. These cells undergo a mesenchymal 
to epithelial transition, forming renal vesicles that rearrange into comma and s-shaped 
stages before terminal nephron segmentation ensues. Waste removal from the blood occurs 
between capillary knots called glomeruli, and a cup-shaped portion of the nephron called 
Bowman’s capsule. In a proximal to distal order, the nephron consists of the capsule, the 
proximal collecting tubule, the loop of Henle and the distal collecting tubule. This distal 
end connects to the UB-derived epithelium, forming a continuous tube. A few early-born 
nephrons appear by E13.5, though the majority form at later stages (Bertram et al., 2000; 
Cebrian et al., 2004). Murine nephrogenesis ceases between P0 and P2 as the CM progenitor 
population is depleted (Brunskill et al., 2011; Hartman et al., 2007). The terminal UB 
tips are remodeled into cascades that connect multiple nephrons. There are approximately 
8,000 nephrons in the neonatal mouse kidney (Cebrian et al., 2004). Recent studies suggest 
nephron endowment in human kidneys may be highly variable, ranging from 200,000 up 
to 1.8 million, though individuals at the low end may be at higher risk of developing renal 
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Figure 1.2 The growth of the kidney in vivo and in culture. (A) From E11.5 on there is 
an exponential increase in tip number. Here the UB is marked by the Hoxb7-myrVenus transgene.  
(B) There is a slight reduction in the average size of the tips through successive rounds of 
branching, though the morphology remains very similar. (C) The kidney grows remarkably well at 
an air-medium interface and was among the first mammalian organs to be successfully grown in 
culture. The morphology of the explanted kidney diverges from that observed in vivo, as the organ 
flattens out and loses its spherical, bean-shaped structure. (D) The UB can be isolated from the 
mesenchyme and cultured in a matrix of extracellular proteins supplemented with GDNF and 
retinoic acid. Strikingly, tip structures are observed in iUB culture, suggesting the branching 
program is to some degree inherent to this epithelium. The restricted domain of Ret expression is 
also preserved, as indicated here by a Ret-GFP knock-in allele. Scale bars: 500 µm
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failure (Hoy et al., 2008; Hoy et al., 2003; Hughson et al., 2003; Nyengaard and Bendtsen, 
1992).
Early specification of the metanephric kidney
 The transcription factor Osr1 is among the earliest known markers of the IM, 
though it is additionally expressed throughout the lateral plate mesoderm (James et al., 
2006; Mugford et al., 2008). Embryos homozygous for an Osr1 null allele form nephric 
ducts, but the mesonephric tubules fail to form and the MM is absent (Mugford et al., 
2008; Wang et al., 2005). The Lim-type homeobox gene Lhx1, similarly, is expressed in 
both the IM and LPM (Tsang et al., 2000). Lhx1-/- embryos exhibit a reciprocal phenotype 
to that of Osr1 in which the MM is present, but nephric duct growth is impaired. While the 
duct does initially form, the caudal portion is absent and consequently kidneys never form 
(Pedersen et al., 2005; Tsang et al., 2000). Consistent with these phenotypes, the original 
expression domains of these transcription factors are restricted from initial widespread IM 
expression to the nephrogenic cord in the case of Osr1 and the nephric duct in the case of 
Lhx1 (Mugford et al., 2008; Tsang et al., 2000). A pair of redundantly acting transcription 
factors, Pax2 and Pax8, appear in the ND after Lhx1 expression is established, though 
they may function epistatically to Lhx1. Pax2/Pax8 double homozygous null mice fail to 
maintain Lhx1 expression and do not form NDs (Bouchard et al., 2002).
 Proper formation of the ND is not autonomous to the IM and requires 
inductive cues from surrounding tissues, including both the axial and paraxial mesoderm, 
as well as the ectoderm. The ectoderm is a rich source of BMPs, while a gradient of a 
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different TGFb family member, Activin, emanates from the axial tissue (Bracken et al., 
2008; James and Schultheiss, 2005).
 Two transcription factors expressed in the early mesenchyme and required for UB 
outgrowth include Wt1 and Sall1 (Kreidberg et al., 1993; Nishinakamura et al., 2001). 
The MM undergoes apoptosis in Wt1-/- embryos. The exact targets of WT1 transcriptional 
activity that mediate MM maintenance remain unknown, however, a recent study employing 
a chromatin immunoprecipitation approach suggests components of BMP signaling 
pathways, a canonical Wnt signaling antagonist, and several chromatin remodeling genes 
are among the major targets of WT1 (Hartwig et al., 2010).
While not required for WD formation, the receptor tyrosine kinase Ret is expressed 
in this structure prior to UB outgrowth. The only early defect in Ret-/- embryos is the failure 
of the caudal end of the WD to fuse with the urogenital sinus (Chia et al., 2011). Much of 
the early genetic activity in the IM is directed towards establishing proper Ret expression. 
Positive regulators include the transcription factor Gata3 (Grote et al., 2006). Canonical 
b-catenin signaling is also required for the early maintenance of Ret expression as Ctnnb1-/- 
embryos fail to maintain Ret levels (Bridgewater et al., 2008).
The GDNF/Ret signaling pathway
Central to normal kidney growth is signaling through the receptor tyrosine kinase 
Ret. Expressed in the Wolffian duct from around E8.5, Ret levels remain high in both 
the WD and ureteric bud up until the T-shape stage. In subsequent rounds of branching, 
Ret is restricted to the tips of the UB (Pachnis et al., 1993; Tsuzuki et al., 1995). Ret is 
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unique among RTKs in requiring a coreceptor for ligand binding. Expression of the GPI-
linked co-receptor Gfra1 mirrors the Ret domain, but extends somewhat deeper in the 
UB and also includes the capping mesenchyme (Towers et al., 1998). The ligand GDNF 
is initially expressed widely in the metanephric mesenchyme prior to UB outgrowth and 
becomes restricted to the capping mesenchyme as branching progresses (Hellmich et al., 
1996; Pichel et al., 1996). The homozygous ablation of any one of these three genes results 
in renal agenesis with a penetrance of greater than 50% (Cacalano et al., 1998; Enomoto et 
al., 1998; Sanchez et al., 1996; Schuchardt et al., 1994). Another GDNF family member, 
Neurturin, is expressed in the UB, however, Ntn-/- mice exhibit no obvious renal defects 
(Widenfalk et al., 1997). Significantly, its preferred coreceptor, GFRa2 is not expressed in 
Ret+ tips, but in the surrounding mesenchymal cells (Yu et al., 1998).
There is a long-standing hypothesis in the literature that localized sources of GDNF 
form chemoattractive gradients that direct branching of the Ret-expressing UB (Sariola and 
Sainio, 1997). Indeed, GDNF coated beads induce ectopic budding when placed adjacent 
to the WD in explanted metanephroi (Sainio et al., 1997). Furthermore, cells of the kidney-
derived epithelial MDCK line exhibit migratory behavior in the presence of localized 
sources of GDNF (Tang et al., 1998). Multiple lines of evidence, however, challenge this 
chemoattraction hypothesis. For one, the forced misexpression of GDNF throughout the 
WD and UB via a transgenic system did not significantly disrupt kidney development 
(Shakya et al., 2005). Most strikingly, isolated UBs cultured in extracellular matrix protein, 
and supplemented with recombinant GDNF, not only exhibit branching behavior, but also 
preserve Ret expression within the tip-like regions (Figure 1.2) (Rosselot et al., 2010). 
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Under these culture conditions there is assumed to be a uniform distribution of GDNF in 
the ECM. 
Positive and negative regulators of Ret signaling
 As GDNF/Ret signaling is central to normal kidney growth, mutations in genes that 
modulate this signaling pathway can in turn have profound effects on development of the 
organ. Several examples have already been provided of transcription factors and secreted 
proteins that first establish GDNF and Ret expression within the intermediate mesoderm. 
GDNF is the primary inducer of UB outgrowth. Addition of exogenous GDNF to cultured 
intact metanephroi often induces the appearance of ectopic UBs from the WD (Pepicelli et 
al., 1997; Sainio et al., 1997). Placement of the primary UB at the appropriate rostro-caudal 
level of the WD is a necessary first step in ensuring the ureter will properly join with the 
bladder (Mendelsohn, 2009). The site of UB outgrowth can theoretically be controlled by 
factors that either sensitize the WD to induction, or limit the domain of instructive cues 
within the mesenchyme.
Several different pathways function in the mesenchyme to limit the site of UB 
outgrowth. One such pathway co-opts a signaling complex (SLIT/ROBO) best known for 
its role in repulsive axon guidance (Piper et al., 2000). The secreted ligand SLIT2 and 
its receptor ROBO2 are both expressed in the MM. Genetic ablation of either the ligand 
or receptor leads to anterior expansion of GDNF within the mesenchyme and frequently 
results in multiplex kidneys with two or more ureters, implying multiple UB induction 
events (Grieshammer et al., 2004). Genetic loss of the RTK antagonist Sprouty1 similarly 
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leads to ureter duplication and abnormally large kidneys that exhibit branching defects 
(Basson et al., 2005; Basson et al., 2006; Rozen et al., 2009). While expressed in the UB 
and MM, Sprouty1 is a target of Ret signaling and most likely acts cell autonomously 
to antagonize RTK signaling, keeping in check a UB that might otherwise overreact to 
inductive cues (Mason et al., 2006). Yet another negative regulator of UB outgrowth is 
mesenchymally expressed Bmp4. Expression of the Bmp antagonist Gremlin in the area of 
the primary budding site relieves Bmp4-dependent inhibition of UB outgrowth (Michos et 
al., 2007; Michos et al., 2004). It remains unclear if this inhibitory effect of Bmp4 is due to 
paracrine signaling that affects the UB, or if it is mediated within the mesenchyme.
Among the positive regulators of Ret expression are the metabolites of Vitamin A. 
It has long been appreciated that Vitamin A deficiency can lead to severe renal hypoplasia 
(Shah and Rajalakshmi, 1984), and more recent studies implicate retinoid signaling as a 
direct regulator of Ret expression. Cultured kidneys treated directly with the vitamin A 
metabolite trans-retinoic acid (RA) exhibit a dose-dependent increase in Ret transcription, 
resulting in increased branching and nephrogenesis when compared to control kidneys 
(Moreau et al., 1998). The effectors of retinoid signaling are transcription factors of the 
RAR and RXR families. The homozygous deletion of two of these transcription factors, 
Rara and Rarb2, which together are expressed in both stromal and UB cells, yields 
hypoplastic kidneys (Mendelsohn et al., 1999; Rosselot et al., 2010). RA treatment of 
isolated UBs stimulates epithelial growth and branching. Furthermore, the expression of a 
dominant negative RAR in the UB abrogates Ret expression, suggesting cell autonomous 
RA signaling, rather than signaling in the stromal population, directly maintains Ret levels. 
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The homeobox transcription factor Emx2 is also required to sustain Ret expression. While 
Ret initially is transcribed in Emx2-/- embryos, expression quickly dissipates and kidney 
development fails (Miyamoto et al., 1997).
Another source of positive regulation manifests as a positive feedback loop between 
the Ret-expressing tips and overlying cap mesenchyme. GDNF signaling stimulates Wnt11 
expression within the UB, specifically in the tip domain in an even more restricted pattern 
than Ret. Paracrine signaling of Wnt11 back to the MM, in turn, maintains GDNF levels 
(Majumdar, 2003). 
The highly pleiotropic nature of GDNF/Ret signaling, with multiple cell autonomous 
and non-autonomous pathways fine-tuning Ret activity, perhaps is the hallmark of 
an adaptive system. These multiple inputs might vary through the course of branching 
morphogenesis and the integration of positive and negative cues results in the appropriate 
responsiveness of tip cells. This highly plastic nature of Ret activation might also underlie 
the surprisingly large range of nephron endowment observed in the human population 
(Hoy et al., 2003). With so many different alleles feeding into GDNF/Ret regulation, it’s 
conceivable the composite regulatory genotype is highly individuated and variable across 
the population. 
A striking example of this plasticity is observed in Spry1/Ret and Spry1/GDNF 
double homozygotes. In a context where the antagonism of RTK signaling by Sprouty1 is 
relieved, GDNF/Ret signaling is no longer required for normal kidney growth; consequently 
these double null embryos develop grossly normal kidneys. This implies other RTKs 
signaling within the tip domain compensate for the loss of Ret activity. Indeed, Spry1/Ret/
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Fgf10 triple null embryos exhibit renal agenesis, suggesting signaling through FGFR2 is a 
major source of this compensatory effect (Michos et al., 2010). 
Cumulative RTK signaling defines tip cell activity
Multiple receptor tyrosine kinases are expressed in the branching ureteric epithelium 
and this RTK profile has recently been comprehensively reviewed (Song et al., 2011). After 
Ret, the most significant activator of downstream signaling is FGR2. The independent 
disruption of FGFR2 ligands Fgf7 and Fgf10 causes relatively minor kidney defects (Ohuchi 
et al., 2000; Qiao et al., 1999b). The conditional ablation of Fgfr2 in the UB, however, 
results in a more severe reduction in branching (Zhao et al., 2004). Met, the receptor for 
hepatocyte growth factor (HGF) is expressed in both the mesenchyme and UB (Woolf et 
al., 1995). Conditional deletion of Met in the UB causes a mild reduction in kidney size, 
accompanied by upregulation of EGFR in the UB (Ishibe et al., 2009). Kidney specific 
deletion of both Met and EGFR results in a more severe reduction of branching (Ishibe et 
al., 2009). While vascular endothelial growth factor signaling is primarily known for its 
role in mediating blood vessel growth, VEGFR2 is expressed in the growing collecting 
system of the kidney (Kanellis et al., 2000). There is in vitro evidence that this receptor 
may directly interact with Ret, and exogenous VEGF-A induces upregulation of GDNF in 
cultured kidneys (Tufro et al., 2007).
In addition to the compensatory growth observed in Spry1/Ret double null kidneys, 
chimeric studies implicate cumulative RTK activity, not just Ret signaling, as crucial 
to defining tip identity. Spry1-/- cells injected into wild-type host embryos preferentially 
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formed the tip domain of the branching UB—the inverse of Ret-/- cell behavior in a mosaic 
setting (Chi et al., 2009b). Undoubtedly, different RTKs act on common downstream 
effectors and induce common transcriptional targets; but it must also be noted that the 
creation of a double null or chimeric embryo are both artificial situations rarely replicated 
in the wild. Individual RTKs thus most likely also bear responsibility for executing unique 
responses to signaling. A known target of Met signaling, for example, is Wnt7b in the 
maturing collecting system (Liu et al., 2009).
The biochemistry of Ret signaling and downstream targets
 The Ret gene is large, spanning 20 exons, and encodes an atypical receptor 
tyrosine kinase. An increasingly complex picture of the biochemistry of Ret signaling has 
emerged since it was first cloned in oncogenic form (Takahashi et al., 1985). While the 
C-terminal cytoplasmic tail of Ret resembles that of other RTKs, it is unique in containing 
a putative cadherin interacting domain and in requiring interaction with a coreceptor, Gfra 
(Iwamoto et al., 1993). There are four different co-receptors, Gfra1-4, and four ligands: 
GDNF, Neurturin, Artemin, and Persephin. Signaling specificity is conferred by preferential 
interactions between certain coreceptor-ligand pairings (Baloh et al., 2000; Baloh et al., 
1998). A crystal structure of Gfra1 reveals very tight binding with GDNF, for example 
(Leppanen et al., 2004). As with other RTKs, ligand binding induces receptor dimerization 
that activates auto-transphosphorylation of tyrosine residues. 
In humans and mice, there are two major isoforms of Ret produced by alternative 
splicing. These isoforms are identical up to residue 1063 and differ only in their C-terminal 
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tails. Named for the number of residues unique to that tail region, both Ret9 and Ret51 
have tyrosines at positions 981, 1015 and 1062. Ret51 contains an additional tyrosine 
residue, Y1096 (Takahashi, 2001).  Phosphorylated tyrosine residues serve as docking 
sites for adaptor proteins needed to activate specific downstream signaling pathways. Grb2 
binding at Y1096, for example, activates the MAPK cascade, while Src binding to Y981 
activates the Raf/Ras pathway (Airaksinen and Saarma, 2002). Both the Ret9 and Ret51 
isoforms are individually sufficient to support normal kidney growth (Hoshi et al., 2012; 
Jain et al., 2006). Confusingly, an earlier study in which mouse/human chimeric Ret9 and 
Ret51 monoisomorphic lines were developed suggested only the Ret9 isoform supports 
normal growth (de Graaff et al., 2001). Nonetheless, the chimeric Ret51 allele provides 
a useful genetic tool, serving as a hypomorphic allele that yields smaller kidneys. The 
genetic disruption of individual tyrosine residues reveals that downstream effectors have 
both unique and redundant roles. Disruption of Y1062 alone is sufficient to recapitulate the 
Ret null allele, implicating major roles for MAPK and PI3K signaling (Jain et al., 2006; 
Jijiwa et al., 2004; Wong et al., 2005). The PLCg pathway, via docking to Y1015, on the 
other hand seems to mediate early Ret-dependent processes, including remodeling of the 
common nephric duct to ensure proper plumbing of the ureter into the bladder (Hoshi et 
al., 2012).
A microarray-based approach was used to identify transcriptional targets of Ret 
signaling by isolating RNA from iUBs treated with and without exogenous GDNF (Lu et 
al., 2009). Several different categories of genes were found to be upregulated by GDNF 
treatment and very few were downregulated. Among the newly identified targets were two 
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redundantly acting transcription factors, Etv4 and Etv5. Eliminating either gene alone does 
not affect kidney development, however, Etv4-/-; Etv5+/- embryos exhibit renal hypoplasia 
and occasionally agenesis. The complete knockout of both alleles leads to complete renal 
agenesis (Lu et al., 2009). Efforts are currently underway to identify the direct targets of 
these ETS family member transcription factors. The transcription of Ret targets additionally 
depends on the redundant activity of the DNA-binding proteins Sox8 and Sox9. Conditional 
deletion of these genes in the UB does not alter Ret expression, however, downstream 
targets, including Etv4 and Etv5 are severely downregulated and normal kidney growth is 
impaired (Reginensi et al., 2011). While Ret signaling does not appear to regulate Sox8/9 
transcription, it is possible the cooperation of these proteins requires post-translational 
modifications induced by Ret activity.
Additional transcriptional targets of Ret signaling include genes that provocatively 
suggest physical mechanisms that may play a role in shaping the branching epithelium. 
Mmp14, which is reduced in Etv4-/-; Etv5+/- hypomorphic kidneys, is a matrix 
metalloproteinase, suggesting ECM remodeling could play a role in branching. In a catalytic 
activity-independent function, MMP14 also serves as a signaling molecule that stimulates 
migratory behavior and persistence in mammary epithelial cells in a dose-dependent 
manner (Mori et al., 2009). Another Ret target, the chemokine receptor Cxcr4, has also been 
implicated in migratory pathways in diverse cell types such as neural progenitors, neural 
crest cells and primordial germ cells (Doitsidou et al., 2002; Odemis et al., 2005). Cxcr4-
/- embryos, however, have a mild kidney phenotype, only occasionally presenting ureter 
duplication. This could be due to compensation from an additional chemokine receptor, 
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Cxcr7, that is also expressed in the UB (Lu et al., 2009). Yet other Ret targets include cell 
cycle regulators and the RTK Met (Lu et al., 2009). 
Cellular processes that effect branching
 This introduction has thus far focused on a rapidly growing body of knowledge 
about the genetic hierarchies employed in kidney development. Dissecting the cell-level 
consequences of this gene activity, however, is a project still in its infancy. As hypotheses 
that localized gradients of chemoattractants shapes the branching epithelium seem 
inconsistent with the data, old questions remain. How, exactly, are cells of the ureteric 
epithelium manipulated to achieve branching? Possible mechanisms include: control of 
cell division or death, oriented cell division, planar cell polarity and convergent extension 
mechanisms, rearrangement of existing cells, differential migratory behaviors among 
UB cells, alterations of the extracellular matrix, and dynamic change within the cellular 
cytoskeleton. Partly, the barrier to addressing these questions has been limited by imaging 
technologies. Our growing ability to visualize and manipulate kidney tissue at a cellular 
resolution will revolutionize understanding of these questions.
 The chimeric studies previously mentioned have proven an informative starting 
point. Ret-/- cells in a wild-type host embryo fail to contribute to the tip domain from 
the earliest stages of branching, as they are excluded from the primary UB. Time-lapse 
imaging of these chimeras further reveals dynamic behavior in the budding Wolfian duct. 
In this context, where there is a heterogeneous mixture of mutant and wild-type cells, the 
wild-type cells rapidly coalesce at the pseudostratified budding region (Chi et al., 2009b). 
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Such behavior could be mediated by hypothetical Ret-dependent migratory properties 
and differential adhesion. While the chimeric situation is to some extent artificial, further 
analysis of mosaically labeled wild-type budding stage Wolfian ducts revealed similar 
sorts of rearrangements, where some cells—possibly those with the highest levels of Ret—
preferentially migrated to the bud site (Chi et al., 2009b).
 The possibility that migratory pathways play a role in branching of the UB has long 
stood as an attractive hypothesis. Pathways implicated in cell migration in other tissues are 
expressed in the kidney and often result in phenotypes when disrupted. One such pathway 
is Semaphorin/Plexin signaling. Semaphorins are signaling proteins that come in secreted, 
membrane-bound and GPI-linked forms. They signal through Plexins, and various family 
members have been established to induce both attractive and repulsive responses in neuronal 
populations (Reidy and Tufro, 2011; Tran et al., 2007). In the kidney, the ligands Sema3a 
and Sema4d decrease branching (via Plxnb1 in the latter case) (Korostylev et al., 2008; 
Tufro et al., 2008). Plxnb2 mutants, however, have small kidneys and exhibit reduced 
branching. Exogenous Sema4C increases branching in culture (Perala et al., 2011). Plxnb2 
has been found to interact directly with the Ret receptor (Perala et al., 2011). It remains 
unclear, however, if these interactions mediate different migratory behaviors in tip cells. 
 The anti-apoptotic factor Bcl2 may also play a role in controlling migratory 
processes within the UB. A primary cell line of UB-derived Bcl2-/- cells exhibited several 
aberrant behaviors. For one, they display increased migratory behavior when compared 
to wild-type UB cells. They additionally have decreased adhesion to ECM substrates and 
are more invasive in a matrix of matrigel (Sheibani et al., 2007). While Bcl2 is normally 
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expressed throughout the UB, the possible inhibition of Bcl2 activity in local areas could 
selectively induce UB cells to branch out. It must be noted that the anti-apoptotic activity 
of Bcl2 also seems to play a role in kidney development. Bcl2 null mice die shortly after 
birth due to renal defects. Their kidneys are hypoplastic as a result of significant apoptosis 
during development (Sorenson et al., 1995). Cell death normally plays no appreciable 
role in UB branching and practically no apoptotic cells are observed within the growing 
epithelium (Michael and Davies, 2004). Like the Bcl2-/- mice, Mmp9-/- mutants exhibit 
increased apoptosis within the UB, though in this case leading to a milder phenotype with 
only a 30% reduction in nephron number (Arnould et al., 2009).
 While there is no appreciable level of cell death in the branching UB, there is a 
low level of proliferation, which is higher in the tips than trunks (Michael and Davies, 
2004; Pepicelli et al., 1997). Localized proliferation could be one means of achieving 
branching, however, mitotic events within the tip domain appear to be randomly dispersed 
(Watanabe, 2004). There is substantial evidence that mitotic events are orchestrated to 
shape the maturing collecting system. Mosaic labeling of mitotic cells in the postnatal 
kidney reveals collecting ducts elongate by oriented cell division. This process appears 
to depend on canonical Wnt signaling, as Tcf2-/- null mutants become cystic with widened 
ducts (Yates et al., 2010). Wnt7b and Wnt9b in particular, may direct this oriented cell 
division. The medullary collecting ducts of the late-stage embryo grow by oriented cell 
division in a Wnt7b-dependent process. This is achieved by paracrine signaling from the 
epithelium to the surrounding interstitium. Ablation of Ctnnb1 in the interstitium replicates 
the Wnt7b-/- phenotype, suggesting a canonical signaling pathway. Interestingly, mitotic 
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events in the absence of medullary Wnt7b are not entirely randomized, but often oriented 
perpendicular to the normal, longitudinal plane of division (Yu et al., 2009). Wnt9b also 
directs oriented cell division in collecting ducts, though through an autocrine mode (Karner 
et al., 2009). Wnt9b additionally seems to direct elongation through a convergent extension 
mechanism reminiscent of planar cell polarity (Karner et al., 2009).
The disruption of various canonical PCP genes in the kidney leads to branching 
phenotypes. The transmembrane protein Vangl2, for example, is a known cell-autonomous 
activator of the Rho Kinase (ROCK) pathway (Ybot-Gonzalez et al., 2007). Vangl2-/- 
mutants have impaired UB branching. Unlike the above-mentioned Wnt mutants, loss of 
Vngl2 doesn’t result in a strong cystic phenotype; rather, the tips of the stunted UB seem 
to be swollen (Yates et al., 2010). Loss of the transmembrane PCP protein Fat4 yields 
smaller kidneys that have dilated tubules (Saburi et al., 2008). Its exact role in ensuring 
normal branching remains unclear, but it has brought new focus to the primary cilia, where 
it normally localizes (Lina and Satlinb, 2004). Activation of these PCP genes in the neural 
tube seems to achieve cell rearrangements via manipulation of the cytoskeleton (Ybot-
Gonzalez et al., 2007).
Indeed, actin dynamics also play a clear role in normal growth of the UB. UB-
specific conditional ablation of both Cofilin and Destrin, two actin depolymerizing factors, 
inhibits normal branching. Cell proliferation seems to occur normally, however, UBs arrest 
at an early budding stage. Cultured isolated UB cells from these double mutants also exhibit 
impaired migration in a scratch assay (Kuure et al., 2010). In another study, isolated UBs 
and cultured kidneys were treated with fluorescently labeled dextran sulfate. The cells of 
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budding regions were found to be wedge-shaped, with actin accumulation on the apical 
side. This lead the investigators to propose a “purse-string” model, wherein actin fibers on 
the apical surface are contracted to create the ballon shape characteristic of the tip regions 
(Meyer et al., 2004).
The evolution of kidney culture techniques has shaped understanding of UB branching
The embryonic kidney was among the first organs to be successfully grown in culture 
conditions. In fact, the intact metanephric kidney grows so well at an air-medium interface 
that it can sustain branching of the UB for up to a week while glomerular structures can 
be seen differentiating from the mesenchyme. These cultured kidneys do not completely 
recapitulate in utero growth. In particular the explanted organ loses its three-dimensional 
structure, growing as a flat mass, and furthermore lacks proper vascular organization. 
The obvious benefits of a stable culture system include the ability to conduct time-lapse 
observations and to introduce manipulations that would not be possible in vivo, such as the 
addition of protein-specific pharmacological inhibitors. Branch patterning can be observed 
via the Hoxb7-GFP and Hoxb7-myristolated-Venus reporter transgenes that specifically 
label the UB epithelium (Chi et al., 2009a).
The kidney can be further separated into epithelial and mesenchymal components. 
While mesenchymal tissue dies without a heterologous inducer, the isolated UB grows 
strikingly well in artificial culture conditions. Early iUB cultures with rat kidneys and 
a mesenchymal cell line-derived conditioned medium, utilized a type I collagen matrix 
(Perantoni et al., 1991). A combination of conditioned medium from an immortalized 
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metanephric mesenchyme cell line (BSN-CM) and the growth factors EGF, HGF, IGF, 
FGF2 and GDNF was found to sustain branching of the iUB suspended within a collagen/
Matrigel matrix (Qiao et al., 1999a). Even more recent attempts to culture the iUB have 
whittled the required exogenous factors down to GDNF and retinoic acid, dispensing with 
the conditioned medium altogether (Rosselot et al., 2010).
Importantly, the behavior of UBs in these culture conditions challenges the long-
standing hypothesis that gradients of mitogenic cues drive branching of the epithelium 
(Sariola and Saarma, 2003). Not only do iUBs have defined tip and trunk-like regions, 
Ret expression is localized to the tip domains (Figure 1.2D). This implies branching 
morphogenesis is, to some extent, intrinsic to the epithelium. If the UB provides a raw drive 
to branch, the mesenchyme might provide more subtle patterning cues. Lung mesenchyme, 
for example, when recombined with iUBs induces a ‘lung-like’ morphology, presenting a 
greater number of lateral branches (Lin et al., 2001). FGF family members additionally 
seem to exert unique pattering effects on the iUB. Recombinant Fgf10, for example, seems 
to promote more gracile trunk growth (Bush et al., 2004; Qiao et al., 2001).
Chapter 2:
Ret-expressing tip cells are self-renewing, 
multipotent progenitors of the renal collecting system
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Introduction
Through careful morphological analysis, it has long been apparent that the arboreal 
structure formed by branching morphogenesis of the ureteric bud differentiates into the 
collecting system of the mature kidney (Grobstein, 1953). There are at least two main cell 
types in the mature collecting system (Schuster, 1993), and cells in different domains (or 
regions) of the actively branching ureteric bud epithelium exhibit a range of transcriptional 
profiles (Brunskill et al., 2008; Yu et al., 2012); it remains unclear, however, whether the 
Wolffian duct and UB harbor a heterogeneous population of epithelial precurors, or a 
single progenitor population capable of yielding all cell types of the collecting system. 
The experiments presented in this chapter explore the hypothesis that the Ret-expressing 
tip cells are a self-renewing, multipotent progenitor population that gives rise to all the cell 
types in the collecting ducts.
The expression of Ret is dynamic across the development of the kidney. Initially 
expressed widely in the Wolfian duct from around E8.5, Ret levels remain high in both the 
WD and ureteric bud up until the T-shape stage. Subsequently, Ret becomes restricted to 
the distal tips of the branching epithelium and is absent from the trunk regions, including 
the ureter (Pachnis et al., 1993; Tsuzuki et al., 1995). Expression of the GPI-linked co-
receptor Gfra1 encompasses the Ret domain, but extends somewhat deeper in the UB 
and also includes the capping mesenchyme (Towers et al., 1998). The ligand GDNF is 
initially expressed widely in the metanephric mesenchyme prior to UB outgrowth and 
becomes restricted to the capping mesenchyme as branching progresses (Hellmich et al., 
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1996; Pichel et al., 1996). The cooperative activity of all three of these molecular actors is 
required for normal kidney growth, as homozygous ablation of any one of these three genes 
results in renal agenesis with high penetrance (Enomoto et al., 1998; Sanchez et al., 1996; 
Schuchardt et al., 1994).
The tip/trunk distinction is not primarily a morphological one—the tips and trunks 
form a continuous epithelium with a lumen and a basement membrane —but, rather, one of 
transcriptional identity. In addition to Ret, the tips are characterized by higher expression of 
targets of GDNF-Ret signaling. The ETS transcription factors Etv4 and Etv5, for example, 
are expressed strongly in the UB tips but not in the trunks (Lu et al., 2009). The genetic 
ablation of three out of four copies of these redundantly acting transcription factors leads to 
renal hypoplasia due to reduced UB branching (Lu et al., 2009). It is a hallmark of tip cells 
that they produce proteins required to sustain branching morphogenesis. Another GDNF 
target, Wnt11, exhibits an even more restricted expression domain than Ret its mRNA 
being found only in the extreme distal tip.. The non-autonomous activity of this secreted 
ligand serves to upregulate GDNF production in the mesenchyme, thus extablishing a 
positive feedback loop that sustains branching (Majumdar, 2003). Transcriptional profiling 
of microdissected UB tips vs. trunks has revealed many additional differences in gene 
expression patterns (Caruana et al., 2006; Schmidt-Ott et al., 2005).
The UB tips also serve as a source of inductive signals required for differentiation 
of the mesenchyme to a nephrogenic fate. A microarray screen comparing the E12.5 
mesenchyme, UB tips and UB trunks, for example, identified two cytokines, CLF-1 and 
CXCL14 as exclusive to the tips (Schmidt-Ott et al., 2005). Isolated mesenchyme treated 
30
with a heterodimer of recombinant CLF-1/CLC underwent an epithelial transition, forming 
structures reminiscent of S-shaped bodies that were positive for Pax2. Wnt9b, produced 
in the trunks and all but the  most distal tip cells, plays a central role in this mesenchymal 
to epithelial transition. While Wnt9b-/- kidneys arrest branching after the T-stage due to a 
failure to maintain GDNF expression, comparison of Wnt9b+/- to null kidneys demonstrates 
a second role in maintaining expression of early epithelial markers in the mesenchyme 
(Karner et al., 2011). With the exception of Wnt9b, signaling molecules produced in the 
trunks mainly serve to effect later-stage maturation of the collecting system. Paracrine 
signaling of Wnt7b in the medullary collecting ducts to the surrounding interstitium through 
a canonical Wnt pathway has been shown to orient cell division along the long axis of the 
tubules. This oriented cell division of the medullary collecting ducts is randomized in late 
gestation embryos lacking Wnt7b (Yu et al., 2009). Wnt9b also mediates this form of planar 
cell polarity, though through an autocrine mode (Karner et al., 2009).
These examples illustrate some of the expression differences between the trunks 
and tips, but it is important to highlight that on the whole, the tips harbor many more unique 
transcripts than the trunks. In one microarray analysis characterizing the E12.5 kidney, 
over 1300 transcripts were found to be UB specific when compared to the mesenchyme. 
Of these, 20.5% were tip specific, while only 8.7% were trunk specific (Schmidt-Ott et 
al., 2005). This observation is consistent with the hypothesis that the tip domain is a less 
differentiated population responsible for executing multiple programs, whereas the trunk 
cells of the UB have a more restricted fate. Indeed, many of the factors unique to the trunk 
are reminiscent of a more differentiated epithelium. Kidney-specific cadherin, for example, 
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in the adult kidney is localized to the basolateral membranes of cells both within the distal 
nephron and entire collecting system, but during developmental stages is only present in the 
trunk regions of the branching UB (Thomson and Aronson, 1999; Thomson et al., 1995). 
Type XVIII collagen is an extracellular matrix protein found in the basement membrane 
and is produced by trunk but not tip cells (Lin et al., 2001). The glycoconjugate-binding 
protein Dolichos biflorus agglutinin (DBA) does not bind to tip cells, but only trunk cells, 
again suggesting the presence of a more mature matrix around these cells. Binding of DBA 
extended to the tip domain when Ret signaling was disrupted in cultured kidneys by a 
siRNA treatment targeting GDNF (Michael et al., 2007).
As early as E14.5 trunk cells begin to produce proteins required for the physiological 
functions of the mature renal collecting system. This system contains two main cell types, 
principal cells and intercalated cells. Nitrogenous waste is filtered from the blood in the 
nephron, but the urine is further concentrated in the collecting system by the resorption of 
water. Approximately 60% of collecting duct cells express the water channels aquaporin 
2 (AQP2), on their apical plasma membrane, and AQP4 on their basolateral membrane 
(Agre et al., 1995; Brown et al., 1988). These principal cells also mediate Na+ homeostasis 
and express apical sodium channels (Brown et al., 1989). Interspersed among these cells, 
mainly in the medullary and cortical collecting ducts, is a smaller population of intercalated 
cells. Responsible for controlling the pH of the filtrate by secreting H+ and HCO3, these 
cells additionally reabsorb the electrolytes Cl and K+ (Schuster, 1991; Schuster and Stokes, 
1987). The identity and function of intercalated cells is further divided into two classes 
defined by the membrane localizations of H+K+ ATPase, a vacuolar H+ ATPase, and a Cl-
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HCO3 exchanger: a-ICs secrete H
+ to the filtrate via apical localization of H+K+ ATPase and 
V1-H+ ATPase, while the basolateral anionic exchanger (AE1) expels HCO3 in exchange 
for Cl (Schuster, 1990, 1993). By virtue of the inverse distribution of these transporters 
(basolateral H+K+ ATPase and V1-H+ ATPase) b-intercalated cells alkalinize the filtrate. 
There is indirect evidence that PCs and ICs may share a common progenitor. 
Differentiating collecting duct cells transiently express the PC marker Aqp2 along with 
carbonic anhydrase II (CARII), which is primarily found in the cytosol of mature ICs 
(Blomqvist et al., 2004; Breton et al., 1995). The forkhead transcription factor Foxi1 
directs a portion of these intermediate progenitors to the IC fate. Foxi1-/- embryos lack ICs 
altogether (Blomqvist et al., 2004). Interestingly, ablation of CarII, which also leads to 
systemic acidosis, similarly increases the number of PCs at the expense of the IC population, 
suggesting the pH of the collecting duct environment itself may play a role in determining 
the IC/PC ratio (Breton et al., 1995). Notch signaling may also play a role in regulating 
this balance, as the PC:IC ratio was decreased in kidneys expressing inactive Mind-bomb1 
(Mib1), an E3 ubiquitin ligase required for endocytosis of Notch ligands in the signaling 
cell—an obligatory process in the activation of the Notch receptor (Jeong et al., 2009).
There is also in vitro evidence of a lineal relationship between collecting duct 
cell types. A primary cell line of b-ICs obtained by fluorescence-activated cell sorting 
gradually differentiated into a-IC and PC types (Fejes-Toth and Naray-Fejes-Toth, 1992). 
An immortalized line of bicarbonate-secreting intercalated cells was sensitive to seeding 
density, exhibiting a b-IC phenotype at low density and switching to an a-IC phenotype 
at high density (Takito et al., 1996). This switch is dependent on the ECM localization of 
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the protein Hensin, which is hypothesized to trigger differentiation by mediating receptor 
activation as it pulls neighboring cells together by polymerizing in the ECM (Al-Awqati, 
2003). This plasticity of IC types is recapitulated in vivo. Pharmacological inhibition of 
carbonic anhydrase causes a depletion of b-ICs in the mature rat kidney and an increased 
number of a-ICs; though, it remains unclear if this is due to increased proliferation of the 
latter population or transdifferentiation of the former (Bagnis et al., 2001).
To summarize, multiple findings suggest cellular identity in the mature collecting 
duct is tightly regulated, but nonetheless amenable to a degree of plasticity as physiological 
conditions change. Arriving at these final differentiated states appears to be a step-wise 
process in which UB cells first exhibit an intermediate identity, expressing both IC and 
PC markers, before settling into a committed role. This program is suggestive of these 
multiple cell types deriving from a common undifferentiated progenitor, but this hypothesis 
has heretofore gone untested. Multiple lines of evidence implicate the tip region of the 
branching UB as the source of such a progenitor. As discussed above, tip cells are more 
transcriptionally diverse than the underlying trunk cells. Validation of these microarray-
based observations by in situ hybridization to specific candidate mRNAs reveals a more 
subtle picture of this arrangement: many genes are not simply ‘on’ in the tips and ‘off 
‘in the trunks, but expressed most highly in the tips and rapidly downregulated in more 
distal cellular positions (Caruana et al., 2006; Lu et al., 2009; Schmidt-Ott et al., 2005). 
It has been hypothesized that UB growth proceeds partly via proliferation in the tip 
domain. While some cells go on to form future tips, a portion are left behind and begin 
to differentiate into the mature CD cell types. Indeed, while overall levels of proliferation 
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in the UB are low (with only 2 to 3% in mitosis at a given time) it is clear there are more 
mitotically active cells in the tips than trunks (Michael and Davies, 2004; Pepicelli et al., 
1997; Watanabe and Costantini, 2004). The most striking support for the tip-cell-as-UB-
progenitor hypothesis comes from examination of chimeras in which only a small portion 
of UB cells express the Hoxb7-mVenus transgene in an unlabeled background. Short-term 
time-lapse imaging of such kidneys reveals that cells within the tip can contribute to both 
future tip and trunk domains as branching proceeds (Costantini and Shakya, 2006; Shakya 
et al., 2005a). From the initial locations of these cells it is inferred they are Ret-expressing 
cells. The experiments presented in this chapter seek to validate this observation using a 
genetic strategy that specifically follows the fate of Ret-expressing tip cells, and to further 
question whether the Ret+ cell population includes progenitors of all collecting duct cell 
types. 
A genetic strategy for tracing the Ret lineage
An inducible genetic strategy was used to follow the fate of Ret-expressing tip 
cells. A Cre-ERT2 fusion protein knock-in to the Ret locus was obtained from Hideki 
Enomoto (Luo et al., 2009) (Fig 2.1A). In this construct, cDNA for the bacteriophage-
derived cre recombinase is fused to an estrogen analog that is responsive to tamoxifen 
binding. While normally present in the cytoplasm, binding of tamoxifen to the Cre-
ERT2 fusion protein will induce nuclear translocation, where the recombinase can act on 
its recombination substrate, 34 bp sequences known as loxP sites (Belteki et al., 2005; 
Danielian et al., 1998). Cre-mediated recombination of identically oriented homologous 
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loxP sites results in excision of the intervening DNA sequence, leaving behind a single loxP 
site. Recombination of oppositely oriented loxP sites causes the reversal of the sequence 
lying between the two sites (Belteki et al., 2005). In knock-in and transgenic strategies, the 
cloning of the Cre cDNA to a specific promoter confers spatial regulation, and the ERT2/
tamoxifen component of the system allows a high degree of temporal control. 
 In short, the aim is to label the Ret-expressing cells in a permanent way such that 
their progeny will also be labeled. This is achieved by crossing animals containing the Ret-
CreERT2 construct to Rosa26-Reporter lines. In these reporters, LacZ or fluorescent protein 
cDNA lies downstream of the ubiquitously active Rosa26 promoter and a transcriptional 
stop cassette flanked by loxP sites. The induction of Cre activity results in the excision 
of the loxP-Stop-loxP sequence, thus allowing reporter expression (Fig 2.1C). In most of 
the experiments presented here, an R26-loxPStoploxP-EYFP reporter was used (Srinivas 
et al., 2001). A second R26R expressing tdRFP was also used, however, this construct 
requires two separate recombination events and is less efficient than the R26R-YFP reporter 
(Bagnis et al., 2001). Induction can be achieved in vivo by injecting the pregnant mother 
with tamoxifen. This molecule must first be converted by the maternal liver to the active 
metabolite 4-hydroxy tamoxifen. Induction in culture can be achieved by adding 4-OHT 
directly to the culture medium. 
 Importantly, the Ret-CreERT2 construct is a null allele. The sequence containing 
CreERT2 was targeted to exon 1 of the Ret locus and also contains a transcriptional stop 
sequence that prevents transcription of the remaining 19 exons (Luo et al., 2009). To 
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Figure 2.1 The Ret-CreERT2 allele and strategy for fate mapping Ret-expressing 
tip cells. The Cre-ERT2 fusion gene was disruptively targeted to exon 1 of Ret, creating a null 
allele (A, adapted from Luo et al., 2009). To confirm the Ret-CreERT2 allele is a functional null, 
heterozygotes were intercrossed to generate Ret-CreERT2/Ret-CreERT2 homozygous mutants. 
While heterozygotes for the knock-in are indistinguishable from totally WT littermates, the 
homozygotes exhibit renal agenesis, recapitulating the Ret null allele (B). To follow the fate of 
Ret-expressing tip cells, Ret-CreERT2; R26R-YFP embryos can be generated and exposed to 
tamoxifen in utero, or 4OH-tamoxifen in culture. Cre-mediated recombination of the loxP-Stop-loxP 
casette in the reporter will lead to permanent expression of YFP in that Ret-expressing cell, as well 
as all of its progeny, even if they lose Ret expression (C). This provides a definitive system for 
testing the fate of Ret-expressing tip cells. If they generate only future tips, YFP+ progeny would be 
absent from the trunks and confined to tips (D). If tip cells are bipotential progenitors, YFP+ cells 





















RetCreERT2/CreERT2 embryos recapitulate the Ret null phenotype, exhibiting highly penetrant 
renal agensis (Figure 2.1B). As kidney development is normal in animals heterozygous for 
Ret knockout (Schuchardt et al., 1994), the use of the Ret-CreERT2 allele is appropriate to 
study the normal fate of Ret-expressing cells. 
Results
Kinetics of RetCreERT2 induction and Cre-mediated recombination
 There is a delay between tamoxifen administration and evidence of recombination 
as assayed by the expression of a reporter. The strength of the promoter driving the 
Cre, the chromatin state of the recombination target and the effective dose of tamoxifen 
received by the target tissue are all variables that factor into the kinetics of induction. Once 
recombined, the target allele must also be transcribed, translated, and reporter protein must 
accumulate past the threshold of detection, which is dependent on the imaging system 
used. Previous studies with tamoxifen-inducible Cre transgenes have consistently shown 
reporter expression in embryonic tissue first becomes detectable around 12 hours after 
intraperitoneal injection of a 2mg/40g or higher dose of tamoxifen into the pregnant mother 
(Hayashi and McMahon, 2002; Nakamura et al., 2006). At such doses, active metabolite 
remains systemic for a roughly 12-hour window (Hayashi and McMahon, 2002). In the 
case of the RetCreERT2/R26R-YFP system used here, this would indicate, for example, 














   
   
   
   
   




























Figure 2.2 In vitro kinetics of Ret-CreERT2 induction with 4-OH tamoxifen. To test 
the in vitro kinetics of Ret-CreERT2 induction, E11.5 Ret-CreERT2; R26R-YFP kidneys were 
explanted to standard culture conditions. A 1-hour pulse of of 4-OH tamoxifen was added to the 
culture medium at a 10µm dose (A-B) or 1µm dose (C-D) before being replaced with fresh 
medium. The effects of leaving the 4-OH tamoxifen in the culture medium were also tested at a 
10µm  (E-F) or 1µm dose (G-H). Recombination was first evident after 6-8 hours. Interestingly, by 
24 hours, the level of recombination seemed equivalent across the conditions tested, suggesting 
saturation of the recombination potential, or a short effective half-life of 4-OH tamoxifen in these 
organ culture conditions. 
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pseudostratifies, would actually result in recombination at the ampulla to T-shape stages of 
ureteric bud growth (E11.0 – 11.5). 
 Spurious recombination was never observed in uninduced RetCreERT2/R26R-YFP 
embryos, suggesting integrity of the inducible Cre and the Rosa reporter allele. Furthermore, 
recombination was observed only in the expected Ret expression domain (e.g., Fig 2.3D), 
suggesting integrity of expression of this modified Ret allele. The shortest interval between 
tamoxifen administration and YFP analysis used in in vivo experiments was around 24 
hours, which proved to be a sufficient interval to drive reporter expression (Figure 2.3D). 
 To establish the kinetics of RetCreERT2 induction in organ culture, E11.5 intact 
metanephroi were explanted to standard kidney culture conditions. As the active metabolite 
4-OH tamoxifen can be applied directly to the target tissue, the lapse till reporter expression 
should be significantly shorter than in vivo. To initiate a transient pulse of induction, 4-OHT 
was added directly to the culture medium and this medium was replaced after a one-hour 
interval. The effect of leaving the 4-OHT continuously in the medium was also tested. 
R26R-YFP expression was evident 8 hours after the beginning of 4-OHT treatment, even 
with a 1-hour pulse of a 1 µm dose (Figure 4.2C). At these earliest time points, ten times 
the dose did lead to a greater initial level of induction (Figure 4.2A). Interestingly, there 
seems to be little difference in the extent and timing of recombination between conditions 
under which the explant is pulsed with 4-OHT for one hour and those in which the drug is 
left in the growth medium, at least by 24 hours later. It is possible that at the doses tested, 
a saturation point of induction is being achieved. It is also possible 4-OHT is unstable in 
the culture conditions used. Even at the highest dose tested, induction was also mosaic, 
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labeling only a portion of the tip cells. Another explanation, albeit unlikely given evidence 
from in situ hybridizations for Ret mRNA, is that not all tip cells express Ret. 
Ret-expressing tip cells are progenitors of the entire collecting system (in vivo results)
 The fate of Ret-expressing tip cells was followed in vivo by intraperitoneal injection 
of a single 2mg dose of tamoxifen to dams harboring litters with RetCreERT2, R26RYFP/YFP 
embryos (Figure 2.3). Injection at E11.5 should culminate in induction that peaks around 
E12.5, (a stage at which Ret expression is clearly confined to the tip domain) and ceases 
by about E13. During a “chase” interval of 6 days of in utero development, the kidney 
completes most of the active stages of the branching program. The E17.5 kidney has over 
700 tips and the trunk regions have begun differentiating towards functional maturity 
(Cebrian et al., 2004). In the E11.5 to E17.5 pulse-chase experiment, YFP+ cells appear in 
all of the terminal tips of the E17.5 kidney and in the entire collecting system, including 
the cortical, medullary and papillary regions (Figure 2.3A). That the labeled cells are 
collecting duct cells is shown by co-staining with anti-GFP and anti-calbindin, a specific 
marker of the collecting ducts (Fig 2.3E-G).  The fact that the tips remain labeled at E17.5 
indicates that these tip cells derive from earlier (E12.5-E13) tip cells; and the labeling of 
cells throughout the collecting ducts at E17.5 indicates that these also derive from the 
E12.5-13 UB tips. Thus, Ret-expressing tip cells are a self-renewing population capable 
of yielding both future tips and trunks. By performing the induction at successively later 
time points and chasing to a common endpoint of E17.5, it is possible to test whether 
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Figure 2.3 Ret-expressing tip cells are self renewing, multipotent progenitors. A 
series of in vivo pulse-chase experiments were performed to determine the normal fate of 
Ret-expressing tip cells. 2 mg of tamoxifen was injected in seperate experiments to dams carrying 
litters of Ret-CreERT2; R26R-YFP embryos at E11.5 (A), E13.5 (B), E15.5(C) and E16.5 (D), all 
chased to the common analysis point of E17.5.  Vibratome sectioning revelas the intitial populations 
of Ret+ tip cells (represented by the in situ hybridizations for Ret mRNA in the top panel) yield all 
future tip and trunk regions. This bipotential fate is not exclusively a hallmark of the earliest 
Ret-expressing cells, but is maintained across the branching program. The level of induction 
achieved with this dose of tamoxifen is not sufficient to saturate recombination in all presumptive 
Ret-expressing cells, however, immunohistochemistry for the collecting system marker calbindin, 
along with YFP, reveals labeled descendents contribute mosaically to all of the tips and trunks in an 
E13.5 to E17.5 pulse chase experiment (E-G). Scale bars: 500 µm
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2 mg Tamoxifen E9.5                     E17.5
2 mg Tamoxifen E8.5                     E10.5
Figure 2.4 Fate mapping of early Ret-expressing cells. Injection of tamoxifen 
around E8.5, which would result in peak recombination from E9.0 to E9.5, mosaically 
labels cells at all rostro-caudal levels of the WD. Even though the WD may still have been 
forming at the time of induction, there is no labeling in the mesenchyme, thus the earliest 
Ret-expressing cells are already committed to a nephric duct fate (A). Tamoxifen injection 
at E9.5, followed by a postpulse chase to E17.5, reveals that Ret-expressing cells 
contribute to the ureter, as well as all portions of the collecting system (B-C). Scale bars: 




E16.5 inductions, the tips, as well as the trunk regions, all contain YFP+ cells at E17.5. Ret-
expressing tip cells thus maintain their ability to self renew and generate trunk cells. With 
a tamoxifen pulse around E11.5, the ureter remains unlabeled, however, earlier inductions 
show that Ret-expressing cells are also progenitors of this structure (Figure 2.4B). 
Time-lapse imaging of in vitro inductions confirms tip cells are self-renewing 
progenitors
 The in vivo results clearly demonstrate that Ret-expressing tip cells are the 
progenitors of future tip and trunk domains. To confirm this self-renewal process in time 
lapse, explanted kidneys grown under standard culture conditions were pulsed with 4-OHT. 
In Figure 2.5A-E, an initially labeled cluster of less than ten tip cells (along with tip cells 
that underwent recombination, but did not express detectable levels of reporter at 8 hours) 
contribute progeny to at least 14 tips and all of the underlying trunk regions. Movies 2.1 
and 2.2 provide examples of the bipotential, self-renewing fate of Ret-expressing tip cells. 
While the levels of mosaicism are too high to follow individual labeled cells, it is clear a 
portion are left behind in the trunk regions as others go on to contribute to growing distal 
tips. In a second example of in vitro time-lapse imaging, the explanted E12.5 kidney was 
again pulsed with 4-OH tamoxifen for a one hour interval. Forty-eight hours later (Figure 
4.5F), recombination should have long since ceased and no new induction events should 
have arisen. In this movie, that lasted for 72 hours, descendents of the labeled Ret+ tip 
























Figure 2.5 Time-lapse imaging of the Ret lineage in culture confirms tip cells are 
self renewing, and also progenitors of the trunks. Ret-CreERT2; R26R-YFP kidneys were 
explanted to standard culture conditions and pulsed for 1 hour with 4-OH tamoxifen to mosaically 
induce the labeling of a small initial number of Ret+ tip cells. Labeled cells are first visible 6-8 hours 
after the pulse (A). Additional recombination events may have occurred but not yet resulted in 
visible levels of YFP at 8 hours. 32 hours later, however, there are no new induction events (B). As 
subsequent rounds of branching ensue (C-E), it is evident that the future tips are derived from Ret+ 
descendants, mirroring the in vivo results (Figure2.3). In a second example, an explanted E12.5 
kidney was pulsed with 4-OH tamoxifen for one hour and replaced with fresh medium. In panel F, 
48 hours after induction, no new recombination events arise. It is clear that labeled tip cells 
contribute to all subsequent tips, while some descendents are left behind in the trunk region (G-N). 
All of the labeled cells distal to the yellow dashed line are derived from the labeled cells distal to this 
line in panel F. By the end of the movie, cells in that cluster contributed to all of the six tips outlined 
in red in panel N. Scale bars: 100 µm
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Ret-expressing tip cells are progenitors of principal cells
 The above studies show that Ret expressing UB tip cells give rise to cells throughout 
the collecting ducts at later stages. However, since labeling of all the CD cells was never 
achieved, the possibility remained that Ret-expressing cells are the progenitors of only 
certain CD cell types, and other CD cell types come from a different, Ret-negative progenitor 
cell population.  Therefore, lineage tracing of Ret-expressing cells was combined with 
immunohistochemistry for a principal cell marker to determine if indeed Ret+ cells yield 
this mature CD cell type. To follow the fate of early Ret-expressing cells, a 2mg dose 
of tamoxifen was injected at E10.5 (resulting in recombination between about E11.0 and 
E12.0) and embryonic kidneys were harvested at E15.5. These kidneys were cryosectioned 
and analyzed by immunohistochemistry for GFP (to identify the YFP+ progeny of labeled 
Ret+ cells) and the principal cell marker aquaporin 2 (Aqp2). Co-labeled cells were found 
in the collecting tubules (Figure 2.6A-C), confirming that Ret-expressing cells at E11-E12 
are progenitors of principal cells. 
 To test if Ret expressing UB tip cells at later stages similarly maintain this 
progenitor ability, tamoxifen was administered at E13.5 and the kidneys were analyzed at 
E17.5. In this experiment, collecting duct cells are first beginning to differentiate around 
the time of induction and mature PCs should be present in the E17.5 kidney. Again, YFP+, 
Aqp2+ cells were apparent throughout the collecting tubules (Figure 2.6D-F), confirming 
Ret-expressing tip cells maintain their ability to yield PCs. In an E17.5 to P0 pulse-chase 
experiment, where only one or two rounds of branching will have occurred, the progeny of 
Ret-expressing tip cells are only found in the tips and a small region of underlying trunk 
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Figure 2.6 Ret-expressing tip cells are progenitors of principal cells. To test the ability 
of Ret+ tip cells to serve as the progenitors of the principal cell type found in the mature collecting 
system, an in vivo pulse-chase of Ret-CreERT2; R26R-YFP kidneys was combined with 
immunohistochemistry for the PC marker, Aquaporin 2. The majority of collecting system cells are 
of the PC type and produce this protein. Many examples of YFP+ cells that colabel with Aquaporin 
2 are evident in early pulse-chase experiments (A-C) and in an E13.5 to E17.5 pulse-chase 
experiment (D-F). With a late gestation tamoxifen pulse, that only labels the peripheral tip cells, 
YFP+ cells do not overlap with the domain of Aquaporin 2 expression. This pattern is consistent 
with the hypothesis that these tip cells are less differentiated progenitors that assume mature 
collecting system identities only once “left behind” in the trunk region (G-I). Scale bars: 50 µm, A-C; 
100 µm, D-I
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(Fig 2.6G-I). These cells do not overlap with the domain of Aqp2 expression. The intensity 
of Aqp2 expression increases from more distal tubules to stronger levels deeper within 
the kidney. These two observations combined suggest the tip cells, while competent to 
yield mature CD cell types, possibly maintain their progenitor state by avoiding terminal 
differentiation.  
Ret-expressing tip cells are progenitors of intercalated cells
 The same experimental approach, of lineage tracing followed by 
immunohistochemistry, was used to test whether Ret-expressing cells are also progenitors 
of the rarer intercalated cell type. YFP+ cells co-labeled with V1-H+ ATPase in the E10.5 
to E15.5 pulse-chase experiment (Figure 4.7A-D). Co-labled cells were also apparent in 
the E13.5 to E17.5 pulse-chase (Figure 4.7E-11). Ret-expressing tip cells are thus also 
progenitors of the ICs of the mature collecting system. Furthermore, they maintain the 
ability to yield ICs throughout the renal branching program. 
 
Discussion
The fate mapping of Ret-expressing cells confirms the hypothesis that these cells 
serve as a bipotential progenitor population capable of yielding both future Ret-expressing 
tip cells and trunk cells that lose Ret expression. The series of  “pulse-chase” experiments, 
in which the Ret-CreERT2/R26R-YFP system was induced in vivo at successively later 
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Figure 2.7 Ret-expressing tip cells are progenitors of intercalated cells. To test the 
ability of Ret+ tip cells to serve as the progenitors of the intercalated cell type observed in the 
mature collecting system, an in vivo pulse-chase of Ret-CreERT2; R26R-YFP kidneys was 
combined with immunohistochemistry for the IC marker, V1-H+ ATPase. Strong polarized 
membrane colocalization of this marker was observed, consistent with normal IC morphology. Early 
Ret-expressing cells are competent to serve this progenitor function, as YFP+ cells in an E10.5 to 
E15.5 chase colabeled with the vacuolar ATPase (A-D). Later-stage Ret+ cells retain this potency, 
as colabeling was observed in an E13.5 to E17.5 pulse-chase experiment (E-L). Arrowheads: 
examples of intercalated cells derived from Ret+ progeny. Scale bars: 50 µm, A-D; 100 µm, E-L
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time points and chased to a common endpoint of E17.5 (Figure 2.3), demonstrates that 
this bi-potnetial ability is not restricted to only the earliest Ret-expressing cells, but is 
maintained throughout the branching program. Strikingly, all of the tips contain YFP+ 
cells in the in vivo inductions, even under conditions in which the induction is mosaic, 
labeling just a portion of the Ret-expressing tip cells (Figure 2.3E-G). It is clear that cells 
throughout the entire collecting system of the metanephric kidney are derived from these 
Ret-expressing progenitors. Even with the highest doses of tamoxifen or 4-OH tamoxifen 
tested, fewer than 100% of UB cells are labeled, in tips and trunks.  This is most likely due 
to technical limitations of the CreERT2 system, but we cannot exclude the possibility that 
some tip cells do not express Ret. 
By E17.5 nephrogenesis is well underway, yet there is no apparent contribution of 
Ret+ descendents to the nephron lineages. This is consistent with the reported fate of Six2+ 
descendents that do not cross the distal nephron/collecting duct boundary (Kobayashi et 
al., 2008). The proportion of the collecting system that remains unlabeled in papillary and 
medullary regions increases with successively later in vivo inductions (Figure 2.3). The 
innermost labeled cells are, most likely, the first to leave the tip domain as a portion are left 
behind in the trunk. These cells thus represent the extent of growth at the time of induction, 
and suggest that trunk cells do not undergo significant positional rearrangements, but rather 
largely stay in place once laid down. These cells divide as the collecting system grows 
(e.g., Fischer et al , 2006), but they do not exhibit the very high proliferative potential of 
individual Ret-expressing tip cells. 
 This proliferative potential is evident in in vitro inductions performed on explanted 
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kidneys. The cluster of less than 10 YFP+ cells in panel A of Figure 2.5, for example, 
partly gives rise to hundreds of progeny and contribute to all of the fifteen tips present in 
panel E. Time-lapse imaging also clearly demonstrates that tip cells yield future tip cells, 
while a portion are left behind becoming trunk cells. In movie 2.2, the labeled cells in the 
two tips initially evident deposit progeny in the growing trunks and contribute to all of the 
successive tips derived through at least four rounds of branching.
 Combining this genetic fate mapping strategy with immunohistochemistry for 
differentiation markers confirms that Ret-expressing tip cells include progenitors of both 
principal and intercalated cell types of the mature collecting system. Injecting 2mg of 
tamoxifen into the dam at E10.5—just as the primary UB is forming—and chasing to 
E15.5 demonstrates that early Ret+ cells have this differential potential, as YFP+ cells co-
label with antibodies for both Aquaporin 2 and V1 H+-ATPase (Figures 2.6 and 2.7). Ret+ 
cells do not lose this potential, as inducing recombination at E13.5 similarly leads to YFP+ 
progeny that co-label with both PC and IC markers. In a relatively short postpulse analysis, 
tip-derived cells are present in only the distal-most trunks of the cortex and do not overlap 
with Aqp2 expression (Figure 2.6G-I). Interestingly, the intensity of Aqp2 expression 
gradually increases in collecting duct tubules, reaching peak levels deeper within the 
collecting system (Figure 2.6I). This again suggests that the Ret+ tip cells constitute a less 
differentiated niche, and that the longer the duration since a CD cell was left out of the tip 
domain the more it has matured. At the induction levels used in this series of in vivo pulse 
chase experiments, multiple cells are labeled per tip, obscuring the lineage of individual tip 
cells. Thus, while as a whole it is apparent that Ret+ cells give rise to both ICs and PCs, 
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it is not clear if individual cells are bipotent; in other words, the tip domain might be a 
heterogeneous compartment of already-committed precursors, all of which express Ret. To 
resolve these alternatives, it is necessary to achieve a level of induction such that just a few 
Ret+ cells are labeled per kidney depositing strings of YFP+ cells that are unambiguously 
clonal. In Figure 4.6, a very large clone of tip-derived cells is evident that encompasses 
at least 50 tips in the newborn kidney and contains, likely, thousands of cells. Individual 
Ret+ cells thus have a tremendous proliferative potential. This observation, combined with 
the fact that CD differentiation seems to be a later stage and gradual process, suggests it is 
highly unlikely Ret+ cells are already-committed precursors. While we are beginning to 
elucidate some of the factors required for terminal differentiation of CD cells, such as the 
role of Notch signaling in rendering IC and PC commitment mutually exclusive, and Foxi1 
in specifying IC identity, much remains to be learned about this process. As a cell exits 
the tip domain and loses Ret expression, it might be sensitized to differentiation signals. It 
remains to be determined what these cues are and where they are produced. It is possible 
that the Ret+ tip cells themselves are a source of inductive cues that pattern the more distal 
collecting ducts. Supporting this hypothesis is the observation that the loss of Ret signaling 
does not lead to premature differentiation, unlike Six2 in the nephron lineage, suggesting 
Ret activity is needed to produce instructive cues. 
 The ability to follow individual Ret-expressing tip cells is germane to not only 
questions of differential potential, but also cell-level processes that may drive renal 
branching morphogenesis. In particular, are mitotic events in the tip domain asymmetric, 
such that one daughter remains in the tip while the other is left behind, or do some divisions 
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result in both progeny remaining in the tip domain. Tip cells can’t strictly obey the first 
possibility. The number of Ret+ cells in the tips of a T-shaped UB is significantly less than 
the collective number in the tips of an E19.5 kidney. This implies there must be expansion 
of the initial Ret-expressing progenitor population. The MADM system (explained in detail 
in Chapter 4) is a powerful and effective tool for achieving low-level mosaicism of labeled 
wild-type cells. In movie 2.3, for example, the behaviors of the totally wild-type red and 
green twin spots vary in a way that may correlate with their positions in the CD. Once 
left in the trunk, the red cell only underwent one round of division, while the green cell 
divided three times as much with all of the progeny remaining in the tip. To confirm that 
such examples aren’t coincidental incidences that confirm the hypothesis, it is necessary 
in future experiments to conduct a quantitative analysis of the behavior of many different 
individual tip cells. 
 The results presented in this chapter beg the important question, what is the role of 
Ret itself in maintaining tip identity. While chimeric analysis of wild-type embryos hosting 
Ret-/- cells clearly shows Ret expression is needed for tips cells to contribute to the primary 
UB (Shakya et al., 2005b), perhaps Ret activity is no longer needed after this critical event. 
Others have argued, that by virtue of its more restricted expression domain, Wnt11 is the 
genuine tip marker (Michael et al., 2007; Sweeney et al., 2008). Most likely, fate mapping 
of Wnt11-expressing tip cells would yield similar results to those reported here for the Ret 
lineage. Wnt11, however, is not needed to regenerate a tip domain upon its disruption, nor 
is it required at all for extensive UB growth and branching (Majumdar 2003). Sweeney and 
colleagues resected the Wnt11+DBA- tips from early stage kidneys and recombined these 
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trunk-only kidneys with E11.5 mesenchyme. The de-tipped kidneys reassembled tip-like 
domains and proceeded to branch. Even the tip of the E12.5 ureter underwent branching 
activity when combined with early mesenchyme (Sweeney et al., 2008). While lacking 
Wnt11, the peripheral trunk cells of the de-tipped kidney might express at least low levels of 
Ret. It is also possible that the actual domain of Ret activity is larger than that predicted by 
RNA localization due to perdurance of the protein. Perhaps stimulation of these lingering 
receptors in the trunk-only kidney is key to reorganizing a tip domain.
 A first step in determining the role of Ret in maintaining tip identity and sustaining 
branching morphogenesis is its conditional ablation after the Ret-dependent formation of 
the primary UB. This question is explored in the following two chapters.
Chapter 3:
A continued role for Ret in the ureteric bud tip domain and 
possible regulative processes of kidney growth
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Introduction
The spatial domain of Ret expression is dynamic and its temporal expression is 
significant, spanning from E8.0, shortly after the establishment of the mesoderm, till the 
first few days after birth. It is highly likely Ret plays multiple roles in the development 
of the urogenital system. While not needed for the formation of the Wolffian duct or 
pseudostratification of the primary budding site, Ret is needed for nephric duct insertion 
into the cloaca (Batourina et al., 2002; Chi et al., 2009), and in most cases, for outgrowth of 
the primary UB into the mesenchyme (Schuchardt et al., 1994, 1996). The early failure of 
kidney development in Ret-/- embryos necessitates the use of conditional genetics to parse 
out subsequent functions. Chimeric analysis where Ret-/- cells were injected into wild-type 
host blastocysts revealed exclusion of null cell from the tips of the UB (Shakya et al., 2005). 
This exclusion occurs via a cell sorting process in which wild-type cells coalesce along the 
pseudostratified region of the WD where the primary bud will form (Chi et al., 2009). As 
Ret-/- cells are excluded from the earliest stages of branching, it is not clear if Ret expression 
must be subsequently maintained for a cell to remain in the tip domain. It is possible the 
critical need for Ret has passed, and while still expressed, branching could proceed normally 
if Ret activity is disrupted at later stages of organogenesis. This possibility is unlikely; Ret-
/- embryos that do form a primary UB always develop hypoplastic kidneys (Schuchardt et 
al., 1996). Ret hypomorphic mutations that allow UB outgrowth (for example, the miRet51 
allele – deGraaff et al.) result in later renal hypoplasia and reduced branching, suggesting 
a continued requirement for Ret. Furthermore, the in vivo lineage tracing of Ret-expressing 
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tip cells described in the previous chapter of this thesis reveals that the bipotential fate of 
these cells as progenitors of both future tips and trunks is not a transient property, but rather 
a continuous fate maintained across all stages of the branching program.
To test for a continued role for Ret, past outgrowth of the primary UB, it is necessary 
to remove Ret from tip cells once the UB is already established. A conditional genetic 
strategy was employed in the experiments described in this chapter, wherein the inducible 
RetCreERT2 allele was used to ablate Ret only within its domain of normal expression. In a 
second set of corollary experiments, rather than removing one gene in a portion of tip cells, 
these cells were mosaically killed off altogether. As Ret-expressing tip cells are progenitors 
of the collecting system, these experiments essentially test if the size of this self-expanding 
progenitor pool limits organ growth.
There are several possible outcomes upon the mosaic loss of a progenitor 
population. If a smaller organ develops, this implies size of the progenitor pool is limiting. 
Cells in this pool might have a predefined proliferative potential, dividing a set number 
of times. Controlling organ growth would thus be achieved by moderating the size of the 
initial progenitor population. Alternatively, size control could be achieved by controlling 
the temporal window in which progenitors expand with unmitigated growth capacity. The 
normal temporal deployment of instructive cues to cease organogenesis would result in 
hypoplasia in the case of a smaller initial pool of progenitors. If, on the other hand, mosaic 
ablation of a progenitor pool results in a normal size organ, this implies a compensatory 
mechanism. A progenitor pool could be replenished by recruitment of new cells. Remaining 
cells within the pool could hyperproliferate to replace lost neighbors. Temporal expansion 
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of the developmental window could lead to a normal size organ. Many examples of 
homeostatic organ size regulation have been discovered in invertebrates, but vertebrates, 
particularly mammals, often have limited capacity for organ regeneration. Size control of 
the developing kidney has gone largely unstudied. 
Clinical evidence indicates the adult kidney is not regenerative in the face of 
traumatic injury. Not only does nephrogenesis completely cease by 36 weeks of age in the 
human kidney, glomerular number decreases across an individual’s lifetime (Nyengaard and 
Bendtsen, 1992). The failure to form new nephrons after early postnatal life is hypothesized 
to be due to the depletion of the progenitor pool in the capping mesenchyme (Kobayashi 
et al., 2008; Rumballe et al., 2011). In species that maintain mesenchymal progenitors into 
adulthood, the potential for nephrogenesis may be preserved. Transfer of labeled nephron 
progenitors between adult zebrafish reveals a continued capacity to form new, functional 
nephrons (Diep et al., 2011). In mammalian kidneys, where nephron progenitors do not 
persist, even the transfer of embryonic capping mesenchyme to adult kidneys would, most 
likely, fail to result in de novo nephron growth, as the inductive environment is lost in the 
adult kidney.
While almost all organs exhibit some level of homeostatic cell turnover, the 
healthy kidney harbors very few dividing cells (Ledda-Columbano et al., 1987). Multiple 
studies suggest cell turnover can partially repair tubular structures in the kidney following 
ischemic injury. The hypoxic conditions induced by ischemic injury create a number of 
secondary problems in the kidney that lead to cell death, both by apoptotic and necrotic 
pathways (Padanilam, 2003). In the case of the collecting system, a tet-on system was 
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used to transiently express a histone 2B-GFP fusion protein during embryonic stages 
of development. Dissection of kidneys from these mice at postnatal stages revealed the 
presence of very few label-retaining cells (LRCs) in the collecting system, with a slightly 
higher proportion of LRCs in the papilla. Many of these remain quiescent, however, a 
portion in the upper third of the papilla undergo proliferation (Adams and Oxburgh, 2009; 
Oliver et al., 2009). Furthermore, following ischemic injury, these LRCs undergo more 
rapid turnover (Oliver et al., 2009). Recovery of nephron tubules following ischemic injury 
is similarly intrinsic to the tubules. A genetic lineage tracing strategy was first used to label 
these nephron cells. Tubules in adult mouse kidneys undergo significant cell loss upon 
ischemic injury, followed by regrowth, in which nearly 60% of the tubular cells are mitotic. 
As the lineage label is not diluted in the restored nephron tubules, the surviving cells after 
the pulse of ischemia underwent restorative expansion, as opposed to rescue by an external 
stem cell (Humphreys et al., 2008). 
To summarize, the adult kidney is incapable of renewing nephrogenesis and, 
presumably, collecting system growth. The extent of regeneration following ischemic injury 
is limited to a sort of space filling model, wherein remaining epithelial cells proliferate to 
restore the loss of neighbors. While these compensating cells are often label-retaining cells, 
they appear to be differentiated tubular cells and not bona fide stem cells. 
While the process of organ recovery in the adult is referred to as “regeneration,” 
the maintenance of proper organ size in the developing embryo is “regulation.” It is 
possible a nonregenerative organ might exhibit regulatory capacity during development to 
achieve a normal size even in the face of cell loss. In the case of the kidney, this possibility 
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remains largely unexplored. An important precedent for this question comes from a study 
conducted in the laboratory of Doug Melton. A tet-off system was used where diphtheria 
toxin (DTA) was autonomously expressed in the progenitors of the pancreas (Pdx1+) or the 
liver (LAP+). Addition of tetracycline prevents transcription of the DTA allele. Ablation of 
pancreatic progenitors up to E10.5 lead to a 60-80% reduction in pancreas size at birth. Even 
after several weeks of postnatal growth, these pancreata did not recover. Depletion of an 
estimated 65% of liver progenitors up to E13.5, however, lead to normal size livers at birth. 
These contrasting results suggest an inherent regulatory growth response in the developing 
liver but not pancreas. Additionally, chimeras with a high proportion of Pdx1-/- cells also 
had small pancreata. These results combined suggest the progenitor pool ultimately limits 
the final organ size of the pancreas (Stanger et al., 2007). Does the developing kidney 
behave more like the pancreas or liver? In particular, does the size of the Ret-expressing 
progenitor pool determine final organ size? An inducible genetic strategy was used in the 
experiments described in this chapter to selectively ablate a portion of the tip cells.
 Final kidney size clearly depends on the robustness of the branching program. 
Embryos homozygous for hypomorphic alleles of Ret have smaller kidneys, while 
inhibition of RTK antagonism by knocking out Sprouty1 can cause an increase in kidney 
size (Basson et al., 2005; Zhang et al., 2008). Many of the genetic mutations that affect 
kidney size also cause morphological abnormalities, like cysts, multiple ureters and branch 
patterning defects. There are only a handful of known mutations that result in smaller, 
but morphologically normal kidneys. Among these are the double-knockout of the UB-
expressed Wnt receptors, Fz4 and Fz8 (Ye et al., 2011). Canonical Wnt signaling almost 
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always effects transcriptional activation, and Wnts have been implicated as mitogenic 
signals in many tissues in many different organisms. Interestingly, mosaic ablation of Fz4 
and Fz8 in the UB shows that double null cells are excluded from the tip regions, much 
like Ret-/- cells in chimeric analysis (Shakya et al., 2005; Ye et al., 2011). If indeed these 
receptors mediate a mitogenic response, this is consistent with the finding that Ret+ tip 
cells serve as progenitors of the UB. This evidence also seems to indicate that the size of 
this progenitor pool might limit final kidney size.
Results
Genetic strategies for mosaically removing Ret and killing UB tip cells
 Inducible genetic strategies were used to both mosaically remove Ret from the 
tip domain and to mosaically ablate tip cells altogether. The RetCreERT2 allele described in 
the previous chapter was again employed to conditionally target these genetic events to 
the tip domain. A conditional Ret allele was obtained, in which exon 12 is surrounded 
by loxP sites (Kramer et al., 2006). This exon encodes the ATP binding site of the kinase 
domain, thus cre-mediated removal of the exon will result in transcription of a kinase dead 
protein (Figure 3.1A).  As the RetCreERT2 allele is itself a null allele (Figure 2.1B), generating 
compound RetCreERT2/Flox mutants and inducing cre is sufficient to mosaically ablate Ret.
 To kill off tip cells, two different Rosa26-floxed-stop-DTA lines were obtained. 
Exogenous diphtheria toxin (DTA) requires a ligand fragment (DTB) to enter cells 
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Figure 3.1 Genetic strategies for conditionally removing Ret in the tip domain and 
killing off tip cells. The tamoxifen-inducible Ret-CreERT2 null allele was used to drive 
recombination of a conditional Ret allele or of the R26-DTA176 allele. Excision of the floxed exon 
in the conditional Ret allele creates a kinase dead protein (A). Cre-mediated excision of the floxed 
transcriptional stop cassette in the R26-DTA176 allele allows cell autonomous transcription of DTA, 
which rapidly leads to cell death (B). To confirm the efficacy of these strategies, these strains were 
crossed to the Hoxb7-Cre transgene strain to remove Ret in the entire collecting system or kill off 
the collecting system altogether. As expected, the Hoxb7-Cre; RetF/F mice develop severely 
hypoplastic kidneys (C-H). The ablation of the nephric duct lineage in the Hoxb7-Cre; R26-DTA176 
cross appears to be efficient, and no kidneys or WD are apparent in these embryos (I-J). a = 
































expressing the diphtheria toxin receptor. Somewhat unique among mammals, mice lack 
this receptor, thus the endogenous expression of DTA should not affect neighbors, leading 
only to strict cell autonomous death (Mitamura et al., 1995). Normally an incredibly potent 
inducer of cell death, it’s been estimated a single molecule of wild-type diphtheria toxin is 
sufficient to kill off a cell (Yamaizumi et al., 1978). The toxicity of the DTA-176 variant is 
attenuated by a mutation in the A-chain catalytic domain that results in a 200-fold reduction 
in efficiency. The inducible DTA mice used in most of the experiments presented in this 
chapter express this DTA-176 variant. Structurally, the transcriptional stop cassette in the 
Rosa26-floxed-stop-DTA176 allele is identical to that in the R26R-YFP allele (Wu et al., 
2006). An additional Rosa26-GFP-floxed-stop-DTA allele was used in a small number of 
experiments (Ivanova et al., 2005). As the coding region for the fluorescent protein falls 
under control of the ubiquitously active Rosa26 promoter, all cells in embryos carrying this 
allele are green. With either allele, spurious cell death due to leaky recombination in the 
absence of cre activity was never observed (Ivanova et al., 2005; Wu et al., 2006).
 To test the efficacy of these conditional Ret and DTA strains, both were crossed 
to strains expressing the Hoxb7-Cre transgene. This transgene is active throughout the 
nephric duct and UB, although it is believed to cause somewhat mosaic deletion of floxed 
genes (S. Kuure and F. Costantini, unpublished data). In Hoxb7-Cre+/-; Retfl/fl newborns, the 
kidneys are severely hypoplastic, recapitulating the phenotype observed in the 30% of Ret-
/- mutants that do form a primary UB (Figure 3.1C). The reduced severity compared to the 
germline Ret knockout is most likely due to incomplete excision of the floxed Ret allele in 
some nephric duct/UB cells. As expected, expression of DTA throughout the Wolffian duct 
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abolishes this structure and prevents kidney development altogether. In E15.5 Hoxb7-Cre+/-; 
Rosa26DTA176/+ mutants, no WD derivatives are evident whatsoever, whereas Rosa26DTA176/+ 
control kidneys are normal (Figure 3.1D).
UB tip cells must maintain Ret expression to sustain normal kidney growth
 To test for a continued requirement for Ret within the tip domain following the 
establishment of the primary UB, the RetCreERT2 strain was crossed to the RetFlox strain. 
Pregnant mothers were injected with 2 mg of tamoxifen at E10.5 or E11.5 and kidneys 
were dissected from the embryos at E13.5. Again, recombination is not instantaneous upon 
tamoxifen injection, but rather peaks between 12-24 hours after intraperitoneal injection into 
the dam (Hayashi and McMahoin, 2002). Two parameters were measured for quantitative 
analysis: 1) the cross-sectional area of the kidney and 2) the number of UB tips per kidney, 
visualized by virtue of the Hoxb7-myrVenus transgene (Chi et al., 2009b) also carried in 
these embryos. Cross-sectional area was determined by photographing freshly dissected 
kidneys on their sides, in the sagittal plane, prior to fixation. Ideally, determination of 
volume or kidney mass would provide more accurate means of expressing organ size, but 
these measurements are too difficult to make on the microscopic scale of the embryonic 
kidney. Tip number provides a good alternative for expressing organ size, as the number of 
tips increases exponentially from E11.5 to E15.5. There are also published quantitations of 
this number for comparison (Cebrian et al., 2004). 
 The average cross-sectional area of E13.5 kidneys in control genotypes was 
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Figure 3.2 The conditional mosaic deletion of Ret in tip cells causes a 
reduction in kidney size. The tamoxifen-inducible Ret-CreERT2 null allele was 
used to drive recombination of  the conditional Ret-Flox allele. Excision of the 
floxed exon 12 creates a kinase dead protein. Inducing deletion of Ret-Flox by 
injection of tamoxifen at E10.5 or E11.5 results in a significant reduction in kidney 
size at E13.5 as measured by either cross-sectional area or tip number (G-H). The 
UB was visualized by expression of Hoxb7-mVenus. Control genotypes at E13.5 
have an average number of 54.4 (+/- 7.4) tips and an average area of 0.51 (+/- 
0.06) mm2, while injection at E10.5 results in mutant kidneys with an average of 
24.9 (+/- 3.7) tips and an area of 0.47 (+/- 0.04) mm2, and induction a day later 
results in an average of 33.0 (+/- 2.8) tips and an average area of 0.48 (+/- 0.05) 
mm2 (H). Unpaired t-tests were used for statistical analyses. In addition to the 




average area of 0.47 mm2 (+/-0.04 mm2) when dissected at E13.5; and in the E11.5 to 
E13.5 experiment, kidneys were also smaller, at 0.40 mm2 (+/-0.05 mm2). The difference 
in average area between control and experimental genotypes in both the E10.5 and E11.5 
injection timepoints was statistically significant (p < 0.0001, Figure 3.2). The reduction 
in average number of tips upon mosaic loss of Ret expression was also significant. The 
average number of tips in the E13.5 control genotypes was 54.4 (+/- 7.4). This is consistent 
with the value of 63.9 (+/- 5.8) reported by Cebrian et al. (2004). In the E10.5 to E13.5 
experiment the average number decreased to 24.9 (+/- 3.7) and in the E11.5 to E13.5 
RetCreERT2/Flox kidneys the average tip number was 33.0 (+/- 2.8). In both cases, this reduction 
in tip number was statistically significant (p < 0.0001, Figure 3.2).
Characterizing the defects in RetCreERT2/Flox mosaic mutant kidneys
 To better characterize the etiology of growth perturbation in kidneys where a portion 
of the tip cells lose Ret expression, a series of analyses were undertaken. Examination of 
UB morphology in embryos expressing Hoxb7-mVenus reveals disruption of the normal 
branching program (Figure 3.3A-B, I-T). While tips in control kidneys are evenly spaced and 
of a consistent size, the tips in mutant kidneys are often smaller, inconsistent in size within 
the same kidney, and irregularly spaced. There are often large gaps within the mesenchyme 
lacking any tips at all. The mode of dichotomous branching is partially preserved, but 
examples were also observed where multiple “micro-tips” seem to be sprouting from one 
ampulla.
 Histological analysis by paraffin sectioning, followed by hematoxylin and eosin 
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Figure 3.3 Ret-CreERT/Flox kidneys have dysmorphic, poorly patterned tips. 
Removing Ret from a portion of the tip cells during the first rounds of branching morphogenesis is 
highly disruptive to normal kidney growth, suggesting a continued requirement for Ret activity 
across the branching program (A-B, I-T). To further characterize the defects in Ret-CreERT/Flox 
kidneys, embryos were pulsed with tamoxifen at E11.0 by maternal injection and embryonic 
kidneys were examined by histological analaysis. Nephron differentiation proceeds in mutant 
kidneys, however, the cortical region is disorganized and tips are dispersed at unusual intervals, 
presumably leaving large patches of mesenchyme devoid of inductive cues (C-D, Yellow 
arrowheads: nascent nephrons). A full-length probe for Ret9 was hybridized in a whole mount in 
situ hybridization. The overall level of Ret mRNA in the tips of mutant kidneys is lower than in 
controls, which could explain the slower organ growth (E-F). In situ hybridization with a probe for 
the Ret downstream target CRLF1 reveals mutant and control kidneys, at least by E13.5, do not 
have differences in intensity of expression of a downstream target gene. This could be due to 
perdurance of mRNA from stages before Ret was mosaically ablated, or from compensation by 
other upstream regulators (G-H). Conditional mutants positive for the Hoxb7-mVenus transgene 
reveal dysmorphic branch patterning. Tips are of variable sizes and unevenly dispersed within the 

































staining, reveals disorganization within the RetCreERT2/Flox kidneys. Nascent nephrons are 
observed, suggesting these kidneys are competent to undergo nephrogenesis. Tubular 
structures are of a similar diameter to those in control kidneys, just fewer in number. The 
capping mesenchyme around the tips seems to be intact; however, the distribution of tips 
in the nephrogenic zone is highly uneven (Figure 3.3C-D). 
 An in situ hybridization with a full-length Ret9 cDNA probe to Ret9 reveals Ret 
expression is not lost in the compound mutant kidneys. The overall intensity of  hybridization 
per tip, however, is qualitatively lower than in control kidneys. Expression analysis of a 
downstream target of Ret, cytokine receptor-like factor 1 (CRLF1), reveals little qualitative 
change in overall level per tip structure between mutant and control kidneys (Figure 3.3E-
F). Either transcriptional levels of this target are not affected by the mosaic loss of Ret, or 
the CRLF1 mRNA perdures through the 2 days following the tamoxifen induction, and any 
change in transcriptional levels would not be reflected until a later dissection time. It is 
important to emphasize that this mRNA visualization technique is not quantitative. There 
must be some alterations in expression levels of Ret downstream targets that account for 
the observed phenotype.
Kidneys treated with recombinant GDNF undergo a significant increase in number of 
cells per tip, possibly suggesting forced Ret activity prevents loss of tip fate
 One possible explanation for the small tips observed upon conditional deletion of 
Ret, is that Ret activity is required to maintain cellular position within the tip domain. 
The small tip phenotype of the conditional mutants would thus be explainable by the loss 
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of mutant cells from the tip domain. Such a hypothesis could be bolstered if the inverse 
were also true, that continued Ret expression should prevent cell exit from the tip. There 
is evidence that tip architecture is dependent on maintaining normal levels of Ret activity. 
Cultured kidneys treated with exogenous GDNF have large, swollen tips, with increased 
levels of Ret expression in tip cells (Pepicelli et al., 1997; Vega, 1996). To determine if this 
phenomenon is due to an increased number of cells per tip and not merely hypertrophy 
of individual tip cells, Hoxb7-mVenus kidneys were explanted to culture conditions and 
treated with 0 or 100 ng of recombinant GDNF. Individual tips were visually dissected by 
confocal microscopy (Figure 3.4). The cross-sectional area of tip cells was approximately 
150 µm2 in both control and GDNF treated kidneys (p = 0.6542, unpaired t-test). The 
average number of cells per tip, however, was significantly different: around 100 cells per 
control tip and 300 cells per GDNF treated tip (p = 0.0024, unpaired t-test).
 This difference could be due to increased proliferation within the tip domain. A 
second explanation is that cells that would otherwise be downregulating Ret expression are 
forced to maintain tip identity as perduring Ret protein is reactivated by the elevated levels 
of ligand. If Ret activity prevents the loss of tip fate, the tips would swell with the ranks of 
these reactivated cells. Of course, testing these hypotheses requires further experiments. 
Ideally, an inducible genetic system could be used to force expression of a constitutively 
active form of Ret.  
The mosaic loss of tip cells causes a reduction in kidney size during embryogenesis
 To test the hypothesis that the size of the Ret+ progenitor pool ultimately limits 
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Figure 3.4 The tips of GDNF treated kidneys swell due to an increased number of 
cells per tip and not cell hypertrophy Kidneys were isolated from E13.5 embryos expressing 
the transgene Hoxb7-mVenus and cultured for 96 hours with 0ng of exogenous GDNF (A) or 100 
ng of recombinant GDNF (E). Confocal microscopy of individual tips was performed to resolve tip 
structure at the cellular level (B-D, F-H). The average cross-sectional area of tip cells in both control 
and GDNF treated kidneys was not significantly different. The number of cells in the tips of GDNF 
treated kidneys, however, tripled (I). The swollen tip phenotype observed in the GDNF treated 
kidneys contrasts with the reduction in tip size observed upon mosaic deletion of Ret in the tip 
domain. One possible explanation to account for these outcomes is that Ret directs the location of 
cells within the UB, such that Ret expression maintains a tip location and its loss leads to cellular 
exit from the tip and into the trunk. If exogenous GDNF treatment essentially forces cells to 
maintain Ret expression, the tip swelling could be accounted for by an inability of these cells to exit 
the tip domain.
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kidney growth, the RetCreERT2 strain was crossed to the R26-Floxed-Stop-DTA176 strain. 
Pregnant mice were injected with 2 mg of tamoxifen at E10.5 or E11.5 and kidneys were 
dissected from the embryos at E13.5. As with the corollary experiments with the conditional 
Ret allele, the same two quantitative parameters were measured: 1) the cross-sectional area 
of the kidney and 2) the number of tips per kidney. 
 The average cross-sectional area of E13.5 kidneys in control genotypes was 0.51 
mm2 (+/-0.06 mm2). A small but significant reduction in size upon tamoxifen injection at 
E10.5 followed by dissection at E13.5 was observed, with an average area of 0.46 mm2 (+/-
0.07 mm2) in mutant genotypes (p = 0.0053, Figure 3.5).  In the E11.5 to E13.5 experiment, 
mutant kidneys had an average area of 0.52 mm2 (+/-0.06 mm2), an insignificant difference 
when compared to controls (p = 0.2727). A significant reduction in average tip number was, 
however, observed in both the E10.5 and E11.5 induction groups. The average number of 
tips in the E13.5 control genotypes was 54.4 (+/- 7.4). In the E10.5 to E13.5 experiment, the 
average number decreased to 32.8 (+/- 5.8) and in the E11.5 to E13.5 RetCreERT2/wt; R26DTA176/
WT kidneys the average tip number was 35.0 (+/- 5.13). In both cases, this reduction in tip 
number was statistically significant (p < 0.0001, Figure 3.5).
 A morphological examination of Hoxb7-mVenus+ kidneys that lose a portion of 
their tip cells shows that, while the average tip number is reduced, these tips are, more or 
less, normally patterned. The mutant kidneys simply appear smaller overall, as if branching 
were merely delayed. This is a less severe phenotype than the kidneys that mosaically 
lose Ret in the tip domain. Of course, such a comparison is only meaningful if the level of 
recombination achieved in the two situations is the same.
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Figure 3.5 The ablation of tip cells causes a reduction in kidney size. 
The tamoxifen-inducible Ret-CreERT2 was used to drive recombination of  the 
R26-DTA176 allele. Excision of the transcriptional stop cassette allows expression 
of the DTA-176 molecule, which will result in strict cell autonomous death. Inducing 
cell death by injection of tamoxifen at E10.5 results in a significant reduction in 
kidney size at E13.5 as measured by cross-sectional area and tip number (G-H). 
Inducing tip cell death a day later, at E11.5, results in no change in area at E13.5, 
but the reduction in average tip number remains significant (H). Control genotypes 
have an average of 54.4 (+/- 7.4) tips  and an average area of 0.51 (+/- 0.06) mm2 
at E13.5. Induction at E10.5 followed by dissection at E13.5 reduces tip number to 
32.8 (+/- 5.8) and kidney area to 0.46 (+/- 0.07) mm2 in mutants, while the average 
mutant tip number in the E11.5 to E13.5 experiments is 35.0 (+/- 5.13) and the area 
is 0.52 (+/- 0.06) mm2. Unpaired t-tests were used for statistical analyses. While tip 
number is reduced in these mutant kidneys, UB morphology appears normal. Tips 





































Efforts to quantify the number of tip cells ablated in conditional experiments
 There is no direct way to measure the level of recombination that occurs in induced 
RetCreERT2/wt; R26DTA176/WT animals. A quantitative PCR approach cannot be used because 
the cells presumably die shortly after recombination and RNA cannot be obtained. An 
alternative is to thus measure the levels of cell death directly. An attempt to do so was 
made by injecting tamoxifen at E11.5 and dissecting the kidneys out exactly 24 hours later. 
These kidneys were cryosectioned and stained for a UB marker, activated caspase 3, as 
well as the mitotic marker phosphoyrlated histone H3. Results show a significant increase 
in caspase3-positive cells in the mutant UB compared to the controls 4.57 (+/- 1.67) cells 
per tip region in mutants  vs. 0.78 (+/- 0.52) in controls (p < 0.0001). (Figure 3.6). A major 
limitation of such a strategy is that the total number of dying cells observed might only 
be a snapshot, and not reflect the total number of cells that died over time as a result of 
tamoxifen induction. Indeed, 4-5 cells per tip region (per section) represents only a small 
fraction of the UB tip cells. No change in the number of mitotic (pHH3+) cells in UB tip 
regions was seen in mutant kidneys versus controls. 
 Time-lapse imaging of induced mutant and control kidneys was performed to 
determine if individual cell death events could be resolved and summed over time. In 
RetCreERT2/wt; R26DTA176/YFP kidney explants treated with 4-OH tamoxifen, exploding, 
presumably necrotic, cell deaths could be observed. A dose of 4-OH tamoxifen was selected 
that lead to a qualitatively similar level of labeling (with the R26R-YFP reporter) seen with 
the in vivo lineage experiments where a 2 mg dose of tamoxifen was injected. Obvious cell 
death events in these time-lapse studies were extremely low in number at less than ten per 
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Figure 3.6 Attempts to quantitate the level of cell death and cell proliferation in 
conditional ablation experiments. To estimate the level of cell death achieved in 
conditional tip cell ablation experiments, tamoxifen was injected at E11.5 and kidneys were 
isolated 24 hours later. Kidneys were cryosectioned and stained for activated caspase 3 to 
mark dying cells and phosphorylated histone H3 to mark mitotic cells. Values are expressed as 
the average number of cells per tips (per section). In a control kidney, the average number of 
dying cells per tips (per section) was 0.78 (+/- 0.52). The level of cell death observed in a 
mutant kidney, 4.57 (+/- 1.67), was significantly higher than the control (p < 0.0001, unpaired 
t-test). The level of proliferation in the mutant and control kidneys, however, was not 
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kidney over a 48-hour time course. One limitation is that the reporter allele and DTA alleles 
are independent and recombination may occur in both in only a small number of cells, thus 
the visible cell deaths vastly underestimate the total.
 As the R26R-YFP allele and the conditional DTA-176 allele are constructed 
identically, with the same floxed transcriptional stop cassette, the kinetics of recombination 
should be highly similar. An appreciable number of tip cells are labeled upon in vivo 
injection of a standard 2 mg/40 g dose of tamoxifen, even when kidneys are dissected only 
24 hours after injection (Figure 2.3A). To estimate the expected level of recombination 
in the RetCreERT2/wt; R26DTA176/WT kidneys, it is worthwhile to determine the level of labeling 
achieved in RetCreERT2/wt; R26RYFP/WT kidneys. 
Mosaically killing off tip cells and removing Ret from tip cells within the same kidney 
does not further reduce kidney growth
 The chronology of results obtained in the conditional tip cell ablation experiments 
shaped the rationale for the following experiment. In the earliest attempts to kill off tip 
cells, recombination was induced by injecting dams at E12.5. RetCreERT2/wt; R26GFP-DTA/WT 
kidneys were no smaller than the kidneys from control littermates. It was only until earlier 
injections (at E10.5) were tested that a reduction in kidney size was observed. Combined 
with the more severe phenotypes observed upon mosaic loss of Ret expression in tip cells, 
these findings led to the hypothesis that mosaic cell death in the tip domain activates a 
compensatory pathway to preserve organ size, while loss of Ret does not activate this 
pathway. If such a phenomenon were indeed occurring, killing off some of the tip 
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Figure 3.7 Killing off cells and ablating Ret from tip cells within the 
same kidney most closely approximates the conditional Ret 
phenotype. The rationale for this experiment was born from early 
observations that induced Ret-CreERT2/DTA176 kidneys exhibit only a mild 
growth defect, whereas the mosaic deletion of Ret leads to a more severe 
phenotype. This suggests loss of Ret is more detrimental than loss of a tip cell 
altogether, and that the death of these Ret mutant cells might partially rescue 
normal growth. To test this hypothesis, a strain where the DTA176 allele was in 
cis with the RetCreERT2 allele was crossed to the Ret-Flox strain. A pulse of 
tamoxifen at E10.5, followed by dissection at E13.5, reveals a failure to rescue 
the dysplastic phenotype. In fact, the mutant kidneys very closely resemble the 
Ret-CreERT2/Flox mutant kidneys, suggesting little to no effect from the 















cells that had lost Ret-expression might mediate a partial rescue of the conditional null 
phenotype. While a somewhat elaborate hypothesis, there are an increasing number of 
studies discovering dying cells secrete mitogenic cues to their healthy neighbors to induce 
compensatory growth (Fuchs and Steller, 2011).
 In order to breed RetCreERT2/Flox; R26DTA176/WT embryos, it was first necessary to 
isolate a meiotic recombinant where the inducible Rosa26 allele is in cis with one of the 
Ret alleles, as Ret and Rosa26 both lie on the distal portion of mouse chromosome 6. A 
RetCreERT2-Rosa26-DTA176/wt line was eventually obtained and crossed to the RetFlox strain. As in the 
above-described in vivo induction experiments, 2 mg of tamoxifen was injected at E10.5 
and embryonic kidneys were isolated at E13.5. Mutant RetCreERT2-Rosa26-DTA176/Flox kidneys are 
smaller than control genotypes. The morphology of the collecting system is highly similar 
to that in the E10.5 to E13.5 RetCreERT2/Flox mutant kidneys, where tips are dysplastic and 
irregularly spaced (Figure 3.7). This suggests that the death of tip cells cannot induce a 
compensatory mechanism as hypothesized. Another possibility is that little recombination 
is achieved with the R26DTA176 allele and an insignificant number of tip cells are dying.
Later recovery of branch patterning and organ size suggests an inherent potential for 
regulatory growth
 While the mosaic loss of Ret expression in the tip domain and the mosaic loss 
of tip cells themselves both lead to smaller kidneys two to three days after induction, 
is this reduced growth permanent, or do regulatory mechanisms work over longer time 
courses to ensure kidneys achieve a normal size? If the size of the Ret+ progenitor pool 
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limits growth, these kidneys should not catch up to control littermates. To test the long-
term compensatory ability of the kidney, tamoxifen was injected at E10.5 or E11.5, stages 
where growth reduction phenotypes were observed, and embryonic kidneys were dissected 
at E17.5. As a technical note, tamoxifen injection seems to have deleterious longer-term 
consequences on the pregnant mother and the rate of miscarriage was very high in the 
experiments. Nonetheless, a small number of RetCreERT2/Flox and RetCreERT2/wt; R26DTA176/WT 
kidneys were recovered at E17.5. 
In the case of the mosaic loss of Ret expression around E12.0 by tamoxifen 
injection at E11.5, the size of the mutant kidneys, as assayed by cross-sectional area, was 
still significantly reduced, averaging around 60% that of controls (Fig 3.8A, B, G). Gross 
inspection of the UB-derived epithelium in these kidneys reveals a clear reduction in the 
number of tips (Fig 3.8A, B). The dysplastic tip morphology observed at E13.5, however, 
does not entirely persist. Four days later, the tips in the mutant kidneys are regular in size 
and well distributed in the mesenchyme (Figure 3.8D). Confocal microscopy of mutant 
and wild-type kidneys expressing the Hoxb7-mVenus transgene confirms a normal tip 
morphology (Fig 3.8C, D). The one notable difference is that tips in the mutant kidneys are 
somewhat larger than those in controls. As there is a gradual reduction in tip size through 
successive rounds of branching during normal development, this observation would suggest 
the mutant kidneys recover to an extent that they resemble wild-type kidneys of earlier 
stage embryos. It remains to be determined if this size difference persists in postnatal life, 
or if the mutant kidneys eventually achieve a normal size given enough time. 
In the case of the mosaic ablation of tip cells, no difference in cross-sectional area 
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Figure 3.8 Partial recovery of kidney growth at later stages of development. To 
test for long-term regulative capacity during kidney development, tamoxifen was injected at 
E11.5 to Ret-CreERT2/Flox and E10.5 to Ret-CreERT2/R26-DTA176 crosses. Kidneys were 
dissected at E17.5 and cross sectional area was measured. Kidneys in which a portion of the 
tip cells lose Ret activity remain smaller with fewer tips (1.81 +/- 0.05 mm2), however, the 
dysmorphic tips observed at E13.5 seem to recover somewhat (C-D). By E17.5 the tips are of 
uniform size and are evenly dispersed (C-D). The average area of kidneys that lose a portion 
of their tip cells (3.09 +/- 0.11 mm2) was not different at E17.5 when compared to controls (3.02 
+/- 0.37 mm2) (E-F). This suggests recovery between E13.5 and E17.5 of the size reduction 







   
   
   
   
   
   
   
   
   





























was observed between wild-type and mutant kidneys induced by injection of tamoxifen at 
E10.5 and dissected at E17.5. Given the significant difference in both area and average tip 
number observed at E13.5, this would indicate these kidneys fully recover in the following 
four days. As the morphology of the mutant tips at E13.5 is essentially normal, this 
recovery is perhaps not surprising given the morphological recovery of the UB in the more 
severe conditional Ret mutants. A quantitation of total tip number was not determined, 
but if indeed the RetCreERT2/wt; R26DTA176/WT mutant kidneys have an equal number of tips to 
control genotypes at E17.5, this would clearly implicate a mechanism for compensatory 
growth as the tip number is reduced four days earlier (Figure 3.5). This could be achieved 
by a combination of proliferation and the addition of an extra round of branching, or the 
extension of the rapid phases of branching, which normally cease around E15.5 (Cebrian 
et al., 2004).
Discussion
The conditional mosaic disruption of Ret within the tip domain confirms the 
hypothesis that Ret plays a continued role in directing UB branching. Tamoxifen injection 
at E10.5 results in peak recombination around the time the primary UB has grown into the 
mesenchyme and formed a swollen ampulla. Injection a day later will mosaically remove 
Ret from the tip cells of the T-shaped UB. In either case, small kidneys are recovered 
in mutant genotypes at E13.5 that additionally exhibit abnormal UB morphology. This 
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finding is consistent with the hypomorphic phenotype expressed in the small fraction of 
Ret-/- mutants that do form a primary UB. Exactly why loss of Ret disrupts branching 
remains less clear. Transcriptional expression of Ret is clearly reduced in the tips of mutant 
kidneys (Figure 3.3E-F). This assault to the robustness of the positive feedback loops in 
the normal branching pathway might manifest in a reduction of mitogenic cues to the UB. 
The size reduction in conditional mutants would thus be a secondary consequence of Ret 
loss. Chimeric analysis, however, suggests a cell autonomous role for Ret signaling in 
maintaining tip cell identity. It is likely this cell autonomous function persists in later stages 
of branching. To understand more about the cell-level consequences of Ret expression in 
the tip domain, it is necessary to follow the fates of tip cells that lose Ret. This aim is the 
subject of the following chapter of this thesis. 
Given the extent of disruption observed upon the mosaic loss of Ret expression, 
the results of the conditional cell ablation experiments were surprising. While killing off a 
portion of the tip cells by tamoxifen injection at E10.5 initially reduces kidney growth (Figure 
3.5), preliminary results suggest subsequent compensation, and recovery of normal organ 
size by E17.5 (Figure 3.8). Possible mechanisms of recovery include hyperproliferation 
of remaining wild-type tip cells upon loss of their neighbors, or temporal extension of the 
branching program to ensure the proper number of tips. While it’s possible to hypothesize 
simple mechanisms of recovery, such phenomena would beg the interesting biological 
question: how does the growing organ “measure” cell loss or size reduction in the first 
place? 
The existence of such a compensatory mechanism in kidney development remains 
83
unproven. More robust controls quantifying the levels of cell death and Ret deletion are 
needed in order to make such a strong claim. Initial attempts to quantitate the level of 
cell death are inconclusive, mainly because temporal snapshots of cell death obtained by 
histological analysis don’t necessarily reflect the total levels of cell death achieved across 
the window of induction. Even though more cell death was observed in the tip sections 
of a mutant than control kidney (Figure 3.6), the overall numbers are extremely low. It 
seems unlikely the loss of two to three cells out of an estimated 100 per tip (Figure 3.4), 
would have much of a consequence on UB growth and branching. The possibility remains 
that a significant level of cell death is simply not being achieved under the experimental 
conditions used. In future experiments to test for long-term regulation of organ size after 
mosaic loss of tip cells, it might be informative to test higher doses of tamoxifen injection. 
Chapter 4:
Mosaic analysis with double markers reveals Ret is required to 
maintain position within the tip domain
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Introduction
The central role of GDNF/Ret signaling in kidney development has long been 
apparent through targeted mutagenesis. The homozygous ablation of the ligand (GDNF), 
receptor (Ret), or co-receptor (GFRa1), most often leads to complete renal agenesis 
(Enomoto et al., 1998; Sanchez et al., 1996; Schuchardt et al., 1994). In chapter 2 of this 
thesis, it was demonstrated that Ret-expressing cells are progenitors of the entire renal 
collecting system. As the branching program progresses, Ret-expressing tip cells maintain 
a bipotential fate, giving rise to both future tips and the trunk regions of the collecting 
system. In the Ret knock-out embryo, dysfunction ensues during the earliest stages of 
kidney development, most often leading to complete renal agenesis, as the caudal Wolffian 
duct never forms a primary ureteric bud. 
To further dissect the role of Ret signaling on the cellular level, and to determine 
whether the defects in Ret null embryos are due to cell autonomous processes, Shakya 
and Costantini analyzed chimeric embryos in which Ret-/- embryonic stem cells carrying 
the transgene Hoxb7-GFP, a marker of the entire UB, were injected into unlabeled host 
embryos. While the Ret-/- cells were found throughout the Wolffian duct, these cells were 
excluded from the primary UB and all future tips, though they did appear in the ureter 
and trunk domains (Shakya et al., 2005). Further studies showed that this exclusion is a 
result of the failure of Ret-/- cells in the Wolffian duct to participate in cell movements that 
establish the primary UB tip domain (Chi et al., 2009). As this early exclusion from the UB 
tips precludes an analysis of any continued role of Ret in maintaining tip cell identity, it 
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was necessary to use a conditional approach to remove Ret from this domain once already 
established. The results presented in the preceding chapter of this thesis demonstrate a 
continued cell-autonomous requirement for Ret within the tip domain. The mosaic loss of 
Ret expression from the tip domain around E11.0 or E12.0 stunts branching morphogenesis, 
yielding hypoplastic kidneys that additionally exhibit branching patterning defects. It thus 
appears Ret is not an incidental marker of the tip cell population, but is, rather, intimately 
tied to the identity of these cells as progenitors. A first step in understanding why this may 
be is to map the fates of tip cells that lose Ret expression. The experiments outlined in this 
chapter address this question with the use of a recently developed inducible genetic system, 
Mosaic Analysis with Double Markers (MADM). 
In traditional conditional genetic systems, it is theoretically possible to concomitantly 
disrupt a gene of interest and label the mutant cell with a second reporter allele. For example, 
to remove Ret in a tip cell and simultaneously label that cell, Ret-CreERT2 mice could be 
crossed to mice harboring both the Floxed-Ret allele and a R26R allele. Recombination 
of each allele is a stochastic event, and under conditions where the level of recombinase is 
limiting to begin with, reporter expression in a cell will not necessarily correlate with Ret 
removal. It is becoming increasingly common for investigators to construct conditional 
alleles in which excision of a portion of the gene of interest brings into frame a reporter that 
will fall under control of the promoter. Indeed, such a conditional allele is available for the 
Ret locus (Jain et al., 2006), but we were unable to obtain it at the time these experiments 
were conducted due to a conflict of interest. The recently developed MADM system 
provided a suitable alternative for following the fate of a cell that loses Ret expression, 
87
and furthermore allowed analyses not possible with the aforementioned conditional allele.
The MADM system
Mosaic analysis with double markers (MADM) is an elegant genetic technique for 
simultaneously knocking out a gene of interest and autonomously labeling the affected cell 
(Muzumdar et al., 2007; Tasic et al., 2012; Zong et al., 2005). This is a cre-mediated event 
that depends upon recombination between loxP sites on homologous chromosomes, thus 
even the strongest of Cre drivers will result in mosaic recombination. The reporter construct 
used here is a combination of two “reciprocally chimeric” alleles, each inserted (in different 
strains of mice) at the Rosa26 locus on chromosome 6. One allele (MADM6GT) contains the 
N-terminus of GFP and the C-terminus of Tomato. The other allele (MADM6TG) contains 
the reciprocal chimeric gene,  including the N-terminus of Tomato and the C-terminus of 
GFP. In each case, these coding regions are disrupted by an intron containing a single loxP 
site (actually an array of noncompatible lox sites, Hui Zong personal communication). In 
a trans-heterozygous cell (MADM6TG/GT), interchromosomal recombination between the 
two MADM alleles can not only rescue a complete fluorescent protein-encoding gene, 
but also rearrange any loci distal to the Rosa26 locus (Figure 4.1B). Recombination in 
a diploid G0 or G1 cell will result in a “yellow” cell (i.e., one expressing both GFP and 
Tomato). The informative recombination events occur post-replication, in tetraploid G2 
cells. Segregation of the four chromatids during mitosis can proceed via two patterns: X 
segregation, in which the rescued GFP and Tomato genes segregate into different daughter 
cells, or Z segregation, in which both rescued genes segregate into one daughter, creating a 
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yellow cell and an unlabeled cell. When a mutant gene of interest lies in cis (and telomeric) 
to one of the two MADM constructs, the G2-X segregation pattern will create a labeled 
daughter cell homozygous for that mutant gene of interest and a differentially labeled wild-
type daughter cell – these red and green sister cells represent “twin spots.” All unlabeled 
cells start out heterozygous for the mutant gene of interest, and all yellow cells remain 
heterozygous (and can therefore be ignored in the analysis). This ability to generate mutant 
and wild-type twin spots is a unique feature of MADM not possible with conventional 
conditional strategies, allowing one to not only compare the behavior of wild-type and 
mutant cells within one tissue, but to monitor for any effects of gene dosage. 
 In addition to the Rosa26 locus, in other mouse strains the MADM constructs have 
been targeted to a region proximal to the centromere of mouse chromosome 11 (Liu et al., 
2011). For reasons that remain unknown, the MADM11 lines are more recombinogenic 
than the MADM6 lines when both are tested with the same Cre drivers. A combination 
of targeted mutagenesis and random integration is underway to extend MADM to every 
chromosome of the mouse genome (Tasic et al., 2012). As the loss of heterozygosity is an 
early step in the etiology of many cancers, both MADM6 and MADM11 mice have been 
used to knock out tumor suppressors: the cyclin-dependent kinase inhibitor p27 (Kip1) in 
the case of MADM6 (Muzumdar et al., 2007), and p53 in the case of MADM11 (Liu et 
al., 2011). Other investigators have also utilized the amenability of the MADM system 
for lineage tracing. Espinosa and Luo demonstrate, for example, that a neuronal precursor 
population in the cerebellum, granule cell precursors, undergoes symmetric division such 
that each granule cell precursor yields an identical number of progeny in postnatal brain 
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development (Espinosa and Luo, 2008). The mosaic nature of MADM induction has also 
been utilized to implicate the cytoplasmic dynein motor-interacting proteins Nde1 and Lis1 
in a surprising cell non-autonomous role in neuronal migration (Hippenmeyer et al., 2010).
Hypothesis and possible outcomes
Based on the exclusion of Ret-/- cells from the primary UB in chimeric analyses, it is 
reasonable to hypothesize that later-stage loss of Ret will similarly result in exclusion from 
the tip domain.  These are not entirely comparable situations, however. In the former case, 
Ret-/- cells are excluded from the very earliest stages of UB formation, whereas in the latter, 
they begin as wild-type cells fully competent to reside in the tip domain, only to lose Ret 
expression at a later stage. There are several conceivable outcomes that could be observed 
with the use of the MADM system to ablate Ret expression. In this system red and green 
twin spots will initially appear as neighbors following a G2-X event. In the hypothetical 
situation illustrated in Figure 2.1C, the red cell is Retwt/wt and the green Ret-/-. If Ret is only 
required for the initial formation of the UB, these sister cells should behave similarly, both 
competent to act as progenitor cells, going on to divide and forming roughly equal numbers 
of daughter cells. In a second scenario, the green null cell might be rendered refractory to 
mitogenic cues upon Ret loss, failing to divide. This cell wouldn’t necessarily be excluded 
from the tip domain, though the red twin cells would produce more daughter cells than 
their green sisters. 
We hypothesize that Ret is required in tip cells to maintain normal branching 





















































Figure 4.1 Mosaically ablating Ret in the tip domain using mosaic analysis with 
double markers (MADM). The MADM construct can rearrange loci distal to its knockin 
location. (A) The MADM6 strategy targeted the Rosa26 locus, located at 52.73 cM on mouse 
chromosome 6. Ret is located approximately 3 cM telomeric. (B) The genotype of labeled cells in 
the MADM system depends on the ploidy of the parent cell at the time of interchromosomal 
recombination. Informative events occur when recombination occurs in a G2 cell. The G2-X pattern 
will segregate both chromatids with both Ret-null alleles in one cell (green in this case), and both 
wild-type alleles of Ret in the sister cell (red in this case). G2-Z segregation leads to a “yellow” (i.e., 
expressing both GFP and Tomato) heterozygous cell and an unlabeled heterozygous cell. (C) 
Recombination in a diploid cell can similarly rescue the fluorescent reporter genes, creating a 
yellow cell that will remain heterozygous for Ret. There are many conceivable outcomes upon the 
loss of Ret in a tip cell previously expressing the gene. While Ret is required for primary UB 
formation, it’s possible that later-stage expression is not central to tip cell identity and red and green 
twin spots will behavior similarly. If Ret is continuously required, it’s possible the null cells will 
largely be excluded from the tip domain. Yet another scenario is that tip cells that lose Ret are 
competent to remain in the tip domain but exhibit a disadvantage, such as decreased proliferation. 
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the growth disruption observed upon conditional deletion of Ret from tip cells in later 
stages of branching support this hypothesis. In the outcome most consistent with this 
hypothesis, green null cells would be largely absent from a tip domain containing wild-
type red cells. Whether null cells are actively extruded from the tip domain or passively 
left out would require further analysis. Possible mechanisms that could account for such an 
outcome include a proliferative advantage conferred by Ret activity, or a cell-autonomous, 
Ret-dependent migratory behavior required for normal branching. 
Results
Breeding schemes and screening for MADM6-Ret-null cis recombinants
As described in Chapter 2, the RetCreERT2 allele is a functional null, which was 
validated by performing the intercross of RetCreERT2/WT heterozygotes. RetCreERT2/CreERT2 
embryos recapitulated the straight Ret-/- phenotype, exhibiting highly penetrant renal 
agenesis (Figure 2.1B). To place a null allele of Ret in cis with the MAD6MTG locus, 
trans-heterozygotes for RetCreERT2 and MADM6TG were crossed to completely wild-type 
mates. Given the reported map distances of these loci (Figure 4.1), approximately 3% of 
the progeny will harbor a recombinant chromosome. The remainder will inherit only the 
chromosome with the RetCreERT2 allele or the MADM6TG allele. To place a null allele of Ret 
in cis with the MAD6MGT locus, trans-heterozygotes for RetCreERT2 and MADM6GT were 
similarly crossed to completely wild-type mates.  This allowed us to (later) generate two 
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sets of mice: one in which the Ret-/- cells would be green and the WT cells red, and one 
in which the Ret-/- cells would be red and the wild type cells green.  We also conducted 
control experiments with MADM6TG/GT recombinant clones, in which no mutant Ret allele 
was present, so both red and green cells would be wild-type.
The 3% expected frequency of meiotic recombinants includes animals that would 
be completely wild-type, thus only 1.5% (1 out of 66 mice) should have a recombined 
chromosome with MADM6TG (or MADM6GT) in cis with RetCreERT2. Overall, of 226 
weanlings screened by PCR analysis of genomic DNA, 7 were recombinant. Four of 
these were completely wild-type, two MADM6TG-RetCreERT2 founders were obtained and 
one MADM6GT-RetCreERT2 founder was obtained. This observed recombination frequency of 
7/226 (3.1%) closely matches the predicted map distance of 3 cM between the Rosa26 and 
Ret loci. The three putative meiotic recombinant mice were crossed to wild-type mates to 
validate the genotype. As expected, all of the progeny genotyped as either completely wild-
type or double heterozygous for both MADM6 and RetCreERT2.
Attempts to induce recombination via RetCreERT2
The intent in using the RetCreERT2 allele as the null allele was that it might also serve 
as the source of recombinase mediating the interchromosomal MADM recombination. In 
other words, upon induction of Cre activity via tamoxifen treatment, informative twin spots 
would only be produced in the tip domain, the region of the UB where Ret is expressed and 
in which loss of Ret might be expected to have an effect on cell behavior. Unfortunately, this 
inducible Cre was never strong enough to drive MADM recombination. Various doses of 
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tamoxifen were tested in vivo and increasingly high doses of 4-OH tamoxifen were applied 
to explanted kidneys (summarized in Table 4.1). Various other inducible Cre lines were also 
insufficient to drive recombination in other tissues (Hui Zong, personal communication). 
Table 4.1
Method of Induction Clones observed / Kidneys analyzed
10 µM 4-OHT in culture from E11.5 0/6
50 µM 4-OHT in culture from E11.5 0/6
6 mg tamoxifen at E11.5, dissected E15.5 0/4
10 µM 4-OHT in culture from E13.5 0/2
100 µM 4-OHT in culture from E13.5 0/4
4 mg tamoxifen at E13.5, into culture at 
E14.5 + 10µM 4-OHT
0/4
6 mg tamoxifen at E15.5, dissected P0 0/4
6 mg tamoxifen at E16.5, dissected P0 0/2
Successful induction with the Hoxb7-Cre transgene
 As an alternative to the inducible RetCreERT2, recombination was driven with the 
Hoxb7-Cre transgene (Yu et al., 2002). In a typical mating scheme to generate green null 
cells, for example, a MADM6TG/+; Hoxb7-Cre+/- mouse could be mated to an MADM6GT-
Ret-/+ individual, generating Hoxb7-Cre; MADM6GT-Ret-;MADM6TG-Ret+ embryos at a 
frequency of 1:8. Even with this stronger transgenic source of Cre, recombination was still 
rare. The earliest recombinant clones observed were in E15.5 kidneys, and even then only 
on the order of roughly 2 to 3 recombination events per kidney. This trend was consistent 
across three separate E15.5 litters examined. Four E15.5 kidneys of the correct genotype 
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didn’t exhibit any recombination at all. The number of Hoxb7+ cells in earlier stage 
kidneys is apparently lower than the frequency at which these very rare interchromosomal 
recombinations occur. As the number of Hoxb7+ cells increases, and as the amount of time 
Cre is active in each cell increases, more recombination events are observed. By P0, tens of 
clones were evident per kidney and this stage was chosen for the initial analysis presented 
subsequently. The other advantage of analyzing P0 kidneys is that it did not require killing 
the mothers, which, because of the complex genetics involved, were in limited supply.
Method of analysis
 The kidneys of newborn mice were dissected from the rest of the body and fixed 
overnight in 4% paraformaldehyde. Only 1:8 mice should have the desired genotype:Hoxb7-
Cre+, and either MADM6GT-Ret-;MADM6TG-Ret+ or MADM6GT-Ret+;MADM6TG-Ret-, 
depending on the experiment. PCR based genotyping was used to identify these P0 mice. 
Kidneys containing clusters of labeled cells (i.e., recombinant clones) were identifiable 
under an epifluorescence dissection microscope and always correlated with the PCR-
determined genotype. Kidneys were vibratome sectioned at a thickness of 100 µm along 
the sagittal plane. The average newborn kidney is about 2 mm thick, yielding 15-20 
vibratome sections. Sections were mounted for epifluorescence microscopy in consecutive 
order. Clusters of cells were observed throughout the P0 kidney. Again, as Hoxb7-Cre 
was used as the driver for the interchromosomal recombination event, twin spots could 
have been induced both in Ret+ tip cells and in non-Ret-expressing trunk cells. As the 
intent of the present study was to follow the fate of tip cells that lose Ret expression, 
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Figure 4.2 Method of analysis. Newborn kidneys were isolated and 
vibratome sectioned at a thickness of 100 µm. Hoxb7-Cre was used to drive the 
interchromosomal recombination, and is expressed throughout the collecting 
ducts, while Ret is expressed in the UB tips. Therefore, clusters of cells located 
only in central regions of the kidney that were assumed to be born outside of the 
tip domain were excluded from analysis (F-H). Informative clusters were those 
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that arose in a UB tip, and were identified by proximity to the periphery of the 
kidney and for having at least one red and/or green cell (B-E). The average and 
median numbers of cells per informative cluster were low, indicating most 
recombination events occurred in later stages of kidney development (I). Dashed 
lines in B-E indicate the periphery of the kidney. All clusters of cells are oriented 
so that the edge of the kidney is on top. Scale bars: 500 µm, A; 100 µm, B-H
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trunk-born recombination events are not informative. Several criteria were used to identify 
informative recombination events: 1) Cell clusters had to contain at least some cells at 
the periphery of the kidney, in the tip region. Based on the lineage-tracing experiments of 
Chapter 2, we assumed that a clone of cells that populates a UB tip as well as the adjacent 
trunk (collecting duct) had derived from a recombination event in a UB tip cell. 2) Clusters 
also had to contain at least two red and/or green cells. Figure 4.2B-E illustrates examples of 
such clear tip-born clusters, while panels F-H illustrate clusters that were assumed to arise 
from recombination within medullary and papillary regions. By and large, most identifiable 
clusters can safely be assumed to be clonal. Due to the very low rate of recombination, only 
very rarely will nearby cells undergo recombination simultaneously. Temporally distant 
recombination events can also obscure an analysis of clonality if the first occurs early and 
the progeny undergo many cell divisions, and then a second recombination occurs in the 
vicinity of this large clone. While assuming that most of the clusters identified are clonal is 
necessary to directly compare the behavior of wild-type and mutant twin spots, the overall 
behavior and numbers of wild-type and mutant cells in the tip region provides a strong 
quantitative means for assessing the behavior of tip cells that lose Ret expression. In cases 
where Hoxb7-Cre was used to drive recombination of totally wild-type twin spots, or wild-
type/mutant twin spots, the average number of cells per cluster was low (Figure 4.2I). In all 
three scenarios analyzed (TG/GT; TG-Ret-/GT; and TG/GT-Ret-) the average total number 
of cells per cluster was around 8 to 10. The median number is lower, around 4 to 6, as the 
average is skewed higher by the presence of a few early-born clusters that have a large 
number of cells. This consistent and low number of cells per cluster suggests the majority 
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of recombination events occurred fairly late in kidney development. The clusters in Figure 
4.2B-E, for example, are reminiscent of the labeling pattern observed in the E16.5 to E17.5 
experiment in the tip cell lineage tracing experiment (Figure 2.3D). 
Red and green cells in completely wild-type controls behave similarly
To analyze the behavior of completely wild-type twin spots, as a control, Hoxb7-
Cre+/-; MADM6TG/GT kidneys were analyzed and informative tip-born clusters were 
identified as described above. In the 71 clusters analyzed, there were an average of 3.8 
green cells per cluster and 4.2 red cells per cluster (Figure 4.3I). These averages are not 
significantly different (p = 0.7958, unpaired t-test). Yellow cells were sometimes found 
within clusters. The most likely explanation is that the red and green twin spots arose from 
one recombination event and the yellow cell(s) from an independent recombination event. 
The average number of yellow cells per cluster was 0.8. A second and rather complicated 
explanation for the presence of these yellow cells (Hui Zong, personal communication) is 
that a G1 recominbation even occurred first (generating yellow cells), followed by another 
recombination in G2 following replication and the chromatids segregated in the G2-X 
pattern, yielding red and green cells.
 In addition to quantifying the number of red and green cells per cluster (when both 
are present), it is informative to consider the frequency with which both red and green cells 
are retained. The majority of clusters in the totally wild-type situation, approximately 70%, 
consist of both red and green cells. No red cells were observed 14% of the time, and no 
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Figure 4.3 MADM6 TG/GT; Hoxb7-Cre: the behavior of wild-type red and green 
twin spots and their descendents. A total of 71 clusters of cells that were deemed to be 
clones born from recombination events within the tip domain were analyzed. A gross visual 
examination of both small clusters (a-n) and large clusters (A-H) reveals both red and green 
wild-type cells contribute to the tip domain. On average clusters contain 3.8 green cells, 4.2 red 
cells and 0.7 yellow cells. Both red and green cells are present in 68.6% of clusters, while 17.1% 
contain red only and 14.3% contain green cells only. Among the clusters that contain both red and 
green cells, the red and green cells share the leading position 47.9% of the time, while red cells 
lead in 29.2% of clusters and green cells lead in 22.9% of clusters (I). All clusters are oriented so 
that the periphery of the kidney is on top. Scale bars: 100 µm
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that the missing cell(s) is obscured from view, or ended up in an adjacent vibratome section. 
The reported rate of cell death in the UB is extremely low and it is unlikely the missing 
twin spots die. It is possible they remain in the kidney, but become far enough separated 
from their twin to no longer be identified as a cluster. It is clear from the lineage tracing 
project presented in chapter 2 that a portion of tip cells are left behind in the normal course 
of branching. One twin could be stochastically left behind as branching continues, ending 
up in a trunk. In a hypothetical situation where two twin cells remain in a tip, but divide at 
a very slow rate, or cease dividing altogether, they could be segregated into different tips 
as branching continues, ending up physically displaced.
 A final analysis made by comparing the behavior of twin spots in clusters where 
both red and green cells are found, was to determine the average distance of the red vs. 
green cells from the periphery of the kidney, using the periphery as a proxy for the UB tips 
(which were not visible per se). This was done in a subjective way by visually estimating 
the average position of red and green cells in a cluster. If the UB tip contained only red 
cells, and green cells were only in the trunk, the cluster was labeled “red leading” (e.g. Fig 
4.3C). In less clear cut cases, the color of cells that appeared closest to the tip, on average, 
were defined as “leading” (e.g., green cells in Fig 4.3D). If  no difference was discerned, or 
if there was any doubt, the cluster was put in the “no difference” category. In Figure 4.3F, 
for example, there is no difference between the green and red twins in terms of leading 
behavior. In 4.3B an example of leading green cells is observed, while the red cells of the 
cluster are in the leading position in 4.3C. No difference in position was observed in 47.9% 
of the red/green clusters in control kidneys, while the red cells were deemed to be leading 
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in 29.2% of clusters and the green in 22.9% (Figure 4.3I). 
 To summarize, in terms of the three parameters analyzed—average number of red 
and green cells per cluster, retention of both twin spots, and positional distribution of twin 
spots—there was no difference between the red and green cells in control kidneys. Most 
clusters contain both red and green cells that appear in similar numbers and have equal 
potential to assume a leading position. 
MADM reveals Ret-/- cells are excluded from the tip domain
To analyze the behavior of tip cells that lose Ret expression, Hoxb7-Cre was used 
to drive interchromosomal recombination in experiments where either the red cells became 
null or the green cells became null. This control of performing the mosaic knockout in 
both directions is important for ruling out the possibility that any modifier alleles on the 
initially isolated recombinant chromosomes are affecting cell behavior. The same analyses 
were performed as described for the wild-type controls. Of the 126 clusters identified in 
red-wildtype/green-mutant kidneys, a large and significant difference was observed in the 
average number of wild-type and Ret-/- cells: clusters contained an average of 7.8 red wild-
type cells and 0.7 green null cells (p < 0.0001, unpaired t-test). Only 4% of the clusters 
contained no red cells, whereas 67.2% of the clusters contained no green cells. In the 35 
clusters where both colors were retained, the wild-type cells were in the leading position 
nearly 70% of the time. No difference was observed 22.9% of the time, however, these 
clusters were small, often containing just one or two cells of each color (e.g., Figure 4.4f). 
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Figure 4.4 MADM6 TG/GT-Ret-; Hoxb7-Cre: green null cells are preferentially 
absent from the tip domain. A total of 126 clusters of cells resulting from recombination events 
in the Ret+ tip domain were analyzed. In both small clusters (a-j) and large clusters (A-G) it is 
overwhelmingly clear the red wild-type cells have a proliferative and positional advantage. On 
average clusters contain 7.8 red cells (median of 4), 0.7 green cells and 1.1 yellow cells. Most 
clusters, 67.2%, contain only red cells, while 4.0% lack red cells and 28.0% contain both. This latter 
category mainly includes clusters with low numbers of cells. Among the clones that contain both red 
and green cells, the red cells assume the leading position 68.6% of the time, while green cells lead 
in 8.6% of clusters, and there is no discernable difference in leading position 22.9% of the time (H). 
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Figure 4.5 MADM6 TG-Ret-/GT; Hoxb7-Cre: red null cells are preferentially absent 
from the tip domain. A total of 129 clusters of cells resulting from recombination events in the 
Ret+ tip domain were analyzed. In both small clusters (a-n) and large clusters (A-C) it is 
overwhelmingly clear the green wild-type cells have a proliferative and positional advantage. On 
average clusters contain 8.3 green cells (median of 2), 1.0 red cells and 0.7 yellow cells. The 
majority of clusters, 53.9%, contain only green cells, while 9.4% lack green cells and 35.9% contain 
both. This latter category mainly includes clusters with low numbers of cells that presumably 
occured later in development. Among the clusters that contain both red and green cells, the green 
cells assume the leading position 55.1% of the time, while red cells lead in 5.8% of clusters, and 
there is no difference in leading position in 39.1% of clusters (D). All clusters are oriented so that 
the periphery of the kidney is on top. Scale bars: 100 µm
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clusters of two (or three?) cells.
Similar results (but with the colors switched) were obtained for Hoxb7-Cre; 
MADM6TG-Ret-/GT kidneys, where the red cells are null for Ret (Fig 4.5). The average number 
of green cells per cluster was 8.3 (median of 2), while only 1.0 red cells were present in 
the average cluster. This difference is significant (p < 0.0001, unpaired t-test). The majority 
of clusters contain only green cells (e.g., Fig 4.5C), while 9.4% contain only red cells 
and 35.9% contain both green and red cells. Green wild-type cells have an advantage in 
assuming the leading position and do so 55.1% of the time, whereas red null cells were 
found to lead in only 5.8% of clusters.
It is overwhelmingly clear that wild-type cells have an advantage in clones that 
apparently arise in the UB tip domain. Not only are Ret-/- cells present in far lower numbers 
within the tip domain (and in the clusters in general), they largely fail to assume a leading 
position at or near the tip and appear deeper within the kidney, in more mature regions of 
the collecting ducts. 
An extreme imbalance in contribution is seen in clusters resulting from early stage 
recombination events
While the exclusion of Ret-/- cells is significant even in clusters composed of a 
small number of cells, the imbalance is exaggerated in clusters with large cell numbers, 
to an extent such that the null cells often seem absent altogether. In the most extreme case 
observed, which occurred in a Hoxb7-Cre; MADM6TG-Ret-/GT kidney, a presumably clonal 





Figure 4.6 A large cluster arising from an early recombination event is grossly 
disproportional in twin spot contribution. In this Hoxb7-Cre; MADM6 TG-Ret-/GT kidney a 
large, presumably clonal, cluster of green wild-type cells spans at least 8 vibratome sections, 
contributes to an estimated 50 tips, and to tubules from the cortex to papilla (A-K). There are no 
obvious red Ret null cells associated with this cluster. This fortuitous recombination event 
demonstrates the signficant proliferative potential of individual tip cells that can yield progeny that 
undergo hundreds of divisions. Scale bars: 500 µm
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estimated 50 tips. This labeling pattern is reminiscent of early tamoxifen pulses around 
E11.5 to E13.5 in the in vivo lineage tracing experiments (Figure 2.3). There are no 
discernable red Ret null cells associated with this cluster of wild-type cells. This labeling 
pattern could be explained by an early recombination event in which the null cell was left 
out of the tip domain before the cell divided, while the green wild-type twin was carried 
in the tip domain, continued to divide, and its progeny were distributed among multiple 
tips. As this occurred in an early stage of the branching program, the size of the wild-type 
twin spot is dramatically amplified through hundreds of rounds of cell division. These cells 
exhibit normal Ret+ tip cell behavior, contributing both to future tips and the trunk region. 
This example illustrates the tremendous proliferative potential of a single tip cell.
Discussion
 The MADM system requires a significant investment in initial setup time as meiotic 
recombinants for the gene of interest and the MADM construct must first be obtained and 
verified in a three-step breeding scheme. A null allele of Ret was successfully placed in cis 
with both the MADM6-GT and TG alleles. To ideally study the fate of tip cells that lose Ret, 
the interchromosmal recombination could be induced by the RetCreERT2 allele. Unfortunately, 
recombination was never observed in this inducible system and the Hoxb7-Cre transgene 
was used as an alternative driver of interchromosomal recombination. Despite the fact 
that recombination can occur anywhere in the collecting system, clusters of labeled cells, 
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representing clearly tip-born clones, were easily distinguished and analyzed. As a control, 
Hoxb7-Cre+/-; MADM6TG/GT kidneys were analyzed, where both the red and green cells are 
completely wild-type. No differences in red and green cell behavior were observed in the 
control experiments, as expected. Clusters contained equal ratios of the two colors and most 
often retained cells of both colors. In kidneys with the experimental genotypes, however, 
there was an overwhelming loss of null cells from the tip domain. Clusters that originated 
in the tip region had significantly higher numbers of wild-type than Ret-/- cells, and the 
mutant cells, when present, were biased towards a position in the trunk. Additionally, the 
majority of clusters contained no detectable null cells whatsoever. Ret expression seems to 
be continuously required for cell proliferation and for maintaining tip cell position. 
 Is this exclusion an active process in which null cells are evicted from the tip 
domain, or are they excluded in a more passive manner? Perhaps differences in proliferation 
could explain a passive model of exclusion. Ret+ tip cells have a clear, strong proliferative 
potential. If a tip cell loses Ret, perhaps it loses the ability to proliferate within the tip 
domain, yet remains competent to stay associated with the tip. Particularly in smaller 
clusters of cells, it appears the null cells are not immediately extruded from the tip domain, 
which is compatible with this explanation. But why then do Ret-/- twinspots rarely appear 
in clusters with large wild-type twinspots? It is clear UB growth proceeds as a portion of 
tip cells are left behind becoming trunk cells. If this is a stochastic process, and a portion 
of tip cells are randomly left behind, the chance of a single non-dividing cell to fall behind 
increases over time. The proliferative potential of tip cells could be directly correlated 
with the levels of Ret signaling, with the strongest activity levels causing an autonomous 
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Figure 4.7 Models of Ret-/- cell exclusion from the tip domain. (A) Proliferation model: 
Immediately following interchromosomal recombination and G2-X segregation, the green 
(wild-type) and red (mutant) twin spots reside as neighbors in the tip domain. If the loss of Ret 
confers a proliferative disadvantage, the green (wild-type) twin spot would go on to divide more 
times than the red (Ret null) twin spot. Both red and green cells would be competent to remain in 
the tip domain, but the green cells continue to divide, increasing the chances that some will remain 
in the tip region. On the other hand, if the wild-type and mutant cells have equal chances of being 
stochastically left out of the tip region, given enough time, the few remaining mutant cells will be 
excluded. (B) Migration model: Perhaps residence in the tip domain requires the continual exertion 
of a migratory behavior by tip cells. If this were a Ret-dependent process, red (Ret null) cells would 
be rapidly excluded from the tips, which would in turn be composed of green cells. The data 
presented in Figures 4.4 and 4.5 are consistent with this latter model, however, it’s still possible that 
proliferative differences alone could account for the exclusion of cells that lose Ret from the tip 
domain.
Migration model of Ret-/- cell exclusion
Proliferation model of Ret-/- cell exclusion
A
B
WT   Ret-/-
WT   Ret-/-
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increase in expression of mitogenic factors. Indeed cell cycle associated genes like CyclinB 
and Myb were found to be targets of Ret activity in a microarray screen (Lu et al., 2009). 
 Another mechanism that could mediate passive exclusion of Ret-/- cells from the 
tip domain is differences in migratory behavior. Mosaic time-lapse imaging of UB cells 
reveals a dynamic epithelium. Continual rearrangements that depend on levels of Ret 
expression could ensure the highest signalers assume a tip position whereas less mobile 
cells are excluded simply by virtue of decreased ability to continually “migrate” into the 
tip domain. The quantitation of the identity of the average leading cells—those that appear 
closest to the periphery of the kidney—reveals that wild-type cells are much more likely to 
assume a “leading” position than Ret-/- cells. In the totally wild-type control kidneys the red 
and green twinspots exhibited equal ability to assume this leading position. 
 Active exclusion of Ret-/- cells from the tip domain could be achieved by cell 
sorting or lateral inhibition pathways. In other epithelial organs that grow by branching 
morphogenesis there is clear evidence of such mechanisms being deployed to enforce cell 
identities. Perhaps the best characterized models are the fly tracheal system and angiogenic 
sprouting in vertebrates. In both cases, tip cell activity is dependent on receptor tyrosine 
kinase signaling (Ferrara et al., 2003; Hellstrom et al., 2007). In the fly trachea, pouches of 
60 cells express Breathless (Btl) an FGFR. The target tissue provides a source of Branchless 
(Bnl), the ligand. Cells with the highest Btl assume tip identity, sprouting filopodia and 
enacting migratory behavior. Initially, lagging cells may also have Btl activity, albeit at 
lower levels. The Notch ligand Delta produced in the tip cells signals to these “stalk” 
cells leading to the lateral inhibition, or at least downregulation, of Btl (Ghabrial et al., 
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2003; Ghabrial and Krasnow, 2006). While such mechanisms could provide an attractive 
molecular explanation for the exclusion of Ret-/- cells in the branching UB epithelium, 
the passive mechanisms of exclusion are more parsimonious. Furthermore, branching of 
smaller tubes with only a few leading cells, like angiogenic blood vessels, is not entirely 
reminiscent of the branching collecting system, where the tip region is composed of a 
hundred or so cells. 
 An important next step in further evaluating these possible explanations is to 
perform time-lapse imaging of MADM6 recombination events that occur in the tip domain. 
The use of the Hoxb7-Cre transgene to drive recombination yields clones only in later stage 
kidneys. These larger metanephroi do not exhibit branching in culture conditions. Ideally, 
it would be possible to induce recombination in the tips of an E11.5 or E12.5 kidney. 
This could perhaps be achieved by breeding the Hoxb7-Cre to homozygosity or using the 





At the outset of this project, the central role of GDNF/Ret signaling in the course of normal 
kidney development had been long established. Germ line deletion of these genes leads 
to highly penetrant bilateral renal agenesis. The 30% of embryos that do develop kidneys 
have consistently hypomorphic organs. Through a combination of chimeric analyses and 
time-lapse imaging, the cell autonomous requirement for Ret in the initial stages of primary 
ureteric bud outgrowth became apparent. A comprehensive catalog of the transcriptional 
targets of Ret-expressing tip cells was emerging. Additionally, the transcriptional profiles 
of other kidney cell types (and their differences from that of Ret+ cells) were being 
systematically cataloged. Questions lingered, however, about the cell-level consequences 
of this transcriptional program and how, exactly, tip cells are manipulated in the process of 
branching morphogenesis to shape the UB. The experiments described in this thesis were 
conceived as new approaches to these questions made possible by the advent of genetic 
techniques to precisely manipulate the spatial and temporal control of gene activity on a 
mosaic level.
 The experiments in Chapter 3 confirm that in addition to being required for the 
earliest steps of metanephric kidney development, Ret is indispensible in later stages of 
kidney growth. The conditional deletion of Ret in a portion of tip cells in the T-shaped UB 
has significant phenotypic consequences: overall kidney size is reduced, as is tip number. 
Furthermore, these tips have an abnormal morphology three days after induction and 
appear smaller than normal stage-matched UB tips. Initial results suggest that the kidney 
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cannot fully recover from the disruptive consequences of the mosaic loss of Ret, as mutant 
kidneys remain smaller than controls at E17.5. Originally conceived as a separate line of 
inquiry into the ability of the kidney to regulate organ size upon cell loss, it later became 
compelling to compare the mosaic ablation of tip cells with the mosaic deletion of Ret 
in tip cells. Surprisingly, the death of UB progenitors lead to a less severe phenotype. 
Even though kidney size was reduced and tip number was decreased in mutants compared 
to controls, the gross morphology appeared normal. In experiments where tip cells were 
killed off early and the kidneys were dissected at the relatively late stage of E17.5, the 
mutant kidneys largely appeared to “catch up” to wild-type controls, achieving a normal 
size as measured by cross-sectional area. An exciting hypothesis to reconcile these different 
outcomes would be that the kidney harbors an inherent regulative ability to compensate for 
UB cell loss and achieve a normal size. The data would indicate such a pathway would not 
be activated upon the deletion of Ret, even though growth is disrupted. While the data in 
Chapter 3 might suggestively corroborate this hypothesis, we cannot fairly compare the 
two conditional manipulations without first accurately quantifying the levels of cell death, 
or Ret deletion, achieved. The levels of recombination in the two situations would have to 
be roughly equal to fairly accept the possibility of an inherent compensatory mechanism. 
Preliminary quantitation suggests that we simply might not be killing as many tip cells as 
we are affecting in the Ret deletion experiments. Completing this quantitation remains an 
immediate next step in this project. Nonetheless, it remains clear that Ret is continuously 
needed within the tip domain to sustain normal organ growth.
 While Ret has a very restricted expression profile in the active stages of UB 
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branching morphogenesis, multiple lines of evidence, and now also the results from 
Chapter 3, implicate the tip cells as a special niche responsible for coordinating both UB 
growth and reciprocal inductive interactions with the overlying nephrogenic mesenchyme. 
The experiments detailed in Chapter 2 tested the hypothesis that Ret-expressing tip cells 
serve as a progenitor population for the growing collecting system, and not just for the tip 
domain. Through conditional induction of the RetCreERT2 allele to drive the permanent 
and heritable expression of a fluorescent reporter, it was shown that Ret+ tip cells are 
indeed a multipotent progenitor population; these tip cells yield both future tips and 
trunks. This fate is not exclusive to the earliest Ret+ tip cells, but is maintained across 
the branching program. By combining in vivo lineage tracing of the Ret+ population with 
immunohistochemistry, it was shown that the progeny of tip-derived cells that end up in 
the trunk regions differentiate into both major cell types of the mature collecting system, 
principal and intercalated cells. It remains to be tested whether individual Ret+ tip cells 
can yield both Aquaporin2 (principal) and V1-H+ ATPase (intercalated) positive cell 
types; however, evidence in Chapter 4 suggests individual tip cells have a tremendous 
proliferative potential, and can give rise to progeny that go on to divide hundreds of times. 
We hypothesize that individual tip cells have a bipotential ability to yield both principal and 
intercalated cell types, rather than positing that Ret+ cells are a heterogeneous population 
of precursors committed to different fates.
  In the preferred model of collecting system development, growth of the epithelium 
proceeds via coordinated activity in the tips. As branching proceeds, some of the tip cells 
are left behind, forming the trunk regions. This establishes a raw branched structure that 
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could secondarily differentiate through the instruction of local inductive cues. Indeed, 
there is evidence that collecting system cell types exhibit a degree of plasticity, even in 
adult organs. This adaptability could maintain vital homeostatic functions mediated by the 
kidney as the organism encounters environmental changes.  Time-lapse imaging of the Ret 
lineage under culture conditions confirms that some tip cells are left behind in the nascent 
trunk regions while others remain in the remodeling tips. To further understand the cell-
level role of Ret in this growth process it is necessary to concomitantly manipulate Ret 
activity and label the altered cell.
 Mosaic analysis with double markers (MADM) provided a powerful approach 
to perform this exact manipulation. This genetic system relies on a cre-mediated 
interchromosomal recombination to create homozygous null and wild-type cells that are 
simultaneously labeled with a genetically linked red or green fluorescent reporter. We used 
this system to knockout Ret in the tip domain after a cell had already established identity as a 
Ret+ cell. Importantly, the level of recombination achieved in this system is extremely low, 
allowing us to unambiguously discern the fates of individual clones. When we generated 
completely wild-type red and green cells within the tip domain, these cells were found to 
behave identically. Both red and green cells divided similar numbers of times; most clones 
contained both the red and green descendents of the initial twin spots; and in clones that 
retained both red and green cells, these cells had equal potential to assume a “leading” 
position, suggesting no differences in migratory behavior.
In initially setting up the MADM system to manipulate the Ret locus, two sets of 
founders were obtained, where a Ret null allele was in cis with either the red reporter or 
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the green reporter. This allowed us, in subsequent experiments, to analyze kidneys where 
the red cells were Ret-/- and the green cells wild-type, or where the red cells were wild-type 
and the green cells mutant. While this setup serves as a control for the unlikely possibility 
that any phenotype observed is due to enhancing alleles on the original recombinant 
chromosomes, it more simply serves as an elegant way to doubly test the same question. 
Indeed, we found in both situations that Ret-/- mutant cells fail to remain in the tip domain. 
Wild-type cells had a vast proliferative advantage and null cells were frequently absent 
from the clones altogether. Furthermore, even in clones with just two cells, the wild-type 
cell exhibited a clear advantage in assuming the leading position.
Ruling out the possibility that null cells are lost to cell death, two possible 
explanations (or a combination thereof) can account for the observed labeling patterns. 
If Ret null cells in the tip domain have a proliferative disadvantage, but aren’t otherwise 
affected, they might remain in place after initially appearing. Their wild-type neighbors 
would go on to divide producing multiple progeny. If a portion of tip cells stochastically 
are left behind, the single null cell and any one of the labeled wild-type cells would have an 
equal chance of being left behind, but as there are many more wild-type cells, a portion will 
always be carried into the future tips. In a second model, a cell autonomous “migratory” 
behavior might be required to maintain position in the tip domain. If Ret-/- cells lose this 
behavior, they fail to migrate into the tips, which quickly would become composed entirely 
of wild-type cells. The near complete elimination of mutant cells observed in our MADM 
analyses would seem more consistent with this second model. Furthermore, even in small 
clones, wild-type cells were significantly more likely to assume the leading position, again 
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suggesting a possible migratory mechanism. On the other hand, the exclusion of null cells 
predicted in the proliferation scenario would depend on the kinetics of cell division and 
number of tip cells that are left behind with each round of branching. If we were able to 
precisely model these parameters, it’s possible we might find proliferation alone is sufficient 
to account for the exclusion of null cells. An immediate aim is to perform live imaging of 
these MADM experiments to gain a better sense of individual cell behavior and further test 
the migration hypothesis. 
 Given these new insights about the behavior of cells that lose Ret in the MADM 
system, it is worth revisiting the conditional deletion data from Chapter 3. While we 
initially predicted that null cells might linger in the tips and disrupt branching by failing to 
carry out essential activities, it appears these cells might, in fact, be quickly excluded from 
the tip domain. The observed growth defect in the conditional Ret deletion experiments 
might then be due to a reduction of tip size. This would also imply that the tip ablation 
experiments did not achieve a very high level of recombination and consequent cell death. 
These observations made with the MADM system also have suggestive implications for 
UB branching morphogenesis in totally wild-type conditions. If indeed loss of Ret leads 
to fairly rapid exclusion from the tip, the control of Ret expression itself (or of specific 
downstream targets) might serve as a switch to define tip size and the rate of trunk growth. 
One way to test such a possibility is to ectopically drive Ret activity in trunk cells. This 
“switch” model would predict that these cells might assume a tip phenotype, and possibly 
rearrange to form a lateral bud. Another experimental possibility is to force tip cells 
to maintain Ret activity (by transgenic expression of a ligand-independent form of the 
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receptor, for example). The model would predict such cells would be unable to exit the tip 
domain, and would never appear in trunk regions. 
 To summarize, the findings presented in this thesis augment our understanding of the 
normal role of Ret in kidney development. In addition to known requirements for Ret in the 
earliest steps of UB outgrowth, this RTK plays a continued role in sustaining the branching 
program. This thesis also confirms that Ret-expressing tip cells function as a self-renewing 
progenitor population that gives rise to the entirety of the collecting system, including 
mature cell types essential to adult kidney functionality. Finally, new insights have been 
made towards understanding the role of cell-level behaviors in shaping the branching renal 
epithelium. Central to these observations was a complex genetic system that only recently 
has become available to investigators in the field of vertebrate development. The ability to 
efficiently perform and image cell-level genetic manipulations in vivo is a new tool in the 
long history of the field of developmental biology, but it will undoubtedly continue to serve 




 Mice were maintained in a pathogen free facility certified by the standards of the 
International Animal Care and Use Committee. For the purposes of embryonic staging, the 
detection of a sperm plug at noon following nocturnal mating was designated embryonic 
stage E0.5. All mouse strains were maintained on either 129SvEv or B6/J backgrounds, 
though necessary intercrossing of strains required mixing of these backgrounds. The 
knockin and transgenic lines used in this research have all been previously described: 
RetCreERT2 (Luo et al., 2009), R26RYFP (Srinivas et al., 2001), RetFlox (Kramer et al., 2006), 
R26flox-stop-slox-DTA (Wu et al., 2006), Hoxb7-mVenus (Chi et al., 2009a), Hoxb7-Cre (Yu et al., 
2002), Hoxb7-Cre-GFP (Zhao et al. 2004), MADM6 (Zong et al, 2005), and MADM11 
(Hippenmeyer et al., 2010).  
Genotyping 
 Genotype identification of weanlings for colony maintenance and of embryos upon 
dissection was performed, in both cases, by a polymerase chain reaction (PCR) approach. 
Tail clippings or embryonic limbs were lysed in 75 µL of an alkaline lysis reagent (25 mM 
NaOH, 0.2 mM disodium EDTA in water) at 95˚C for one hour. Lysis was neutralized with 
an equal volume of Tris-hydrochloride (40 mM in water). In most cases, 1 to 2 µL of this 
DNA preparation was sufficient for all of the primer sets used. The following primers, in 5’ 
to 3’ sequence, were used for genotyping at the indicated annealing temperatures:








































Expected product sizes: 350 base pairs for wild-type; 230 base pairs for knock-in
In vivo lineage tracing
 To follow the fate of Ret-expressing tip cells and their progeny in vivo, dams harboring 
RetCreERT2/+; R26RYFP/+ embryos were injected with 2 mg tamoxifen (Sigma) dissolved in 
sunflower seed oil (Invitrogen), at the stages indicated in the text. Kidneys were recovered 
after the stated post-injection intervals, and were fixed overnight in 4% paraformaldehyde 
at 4˚C. Following several rounds of washing in PBS, kidneys were embedded in the sagittal 
plane in 3% agarose dissolved in PBS. Serial vibratome sectioning at a thickness of 100 µm 
was performed. To visualize YFP+ cells, these vibratome sections were treated identically 
to the cryosections in the immunohistochemistry protocol described subsequently. 
Immunohistochemistry
 To determine the contribution of Ret-expressing tip cells to the principal and 
intercalated fates, as described in Chapter 2, and to identify cell death and proliferation 
in the conditional Ret deletion and cell ablation experiments presented in Chapter 3, a 
common immunohistochemistry protocol was used. Embryonic kidneys were isolated and 
fixed overnight at 4˚C in 4% paraformaldehyde in PBS. After washing three times in PBS, 
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kidneys were equilibrated successively in 15% sucrose/PBT followed by 30% sucrose/
PBT. Kidneys were mounted in the sagittal plane in OCT compound (Tissue-Tek) and 
frozen in a dry ice/alcohol bath. Cyosections were recovered at 6 µm and stored at -20˚C. 
 To detect protein expression, sections were post-fixed in methanol for 15 minutes 
and treated with a blocking solution of 2% donkey serum in PBT. Primary antibodies were 
diluted 1:100 – 1:200 in PBT, applied to slides via parafilm coverslipping, and incubated 
overnight at 4˚C. Following at least 3 washes with PBS, secondary antibodies linked to the 
indicated fluorescent reporters were applied overnight at 4˚C (Jackson ImmunoResearch). 
Slides were rinsed several times in PBS and mounted with Fluoro-Gel (Electron 
Microscopy Sciences). In some cases, sections were also counterstained with Hoecsht 
prior to mounting. The primary antibodies used were raised against GFP (Rockland and 
Invitrogen), phosphorylated histone H3 (Promega), activated caspase 3 (Cell Signaling), 
V1-H+ ATPase (Santa Cruz), aquaporin 2 (Sigma), and calbindin (Santa Cruz). 
Live organ culture and time-lapse imaging
 All in vitro induction experiments described in Chapter 2, including the time-
lapse movies, were performed under culture conditions as described (Riccio and Michos, 
2012). Intact metanephroi were cultured on filters at an air/medium interface. Specifically, 
Transwell tissue culture plates constructed of a polyester membrane with a 0.4 µm pore 
size were suspended in 35 mm culture dishes or 6-well cell culture plates. Medium was 
placed below the filter, but not on top. Primary culture medium was composed of D-MEM/
F12 (Gibco) with 10% fetal calf serum, and 0.1 unit/mL of penicillin/streptomycin . The 
125
growth medium was not supplemented with additional factors, with the exception of 
the experiment desribed in Figure 3.4, in which 100 ng/mL of recombinant rat GDNF 
(R&D) was added directly to the primary medium. Explanted kidneys were incubated in a 
humidified 37˚C environment containing 5.0% CO2. Culture medium was replaced every 
48 hours. 
 Kidneys were imaged on a Zeiss AxioObserver Z1 epifluorescence microscope or 
a Zeiss 510 META confocal microscope. In all time-lapse movies, images were aquired at 
a rate of 2 frames per hour. 
Quantitation of organ size
 Two different methods to quantify organ size were used in the conditional Ret 
deletion and tip cell ablation experiments described in Chapter 3: (1) the cross-sectional 
area of freshly dissected kidneys was measured (2) the number of tips per kidney was 
counted. Kidney area was measured by photographing freshly dissected kidneys in the 
sagittal plane prior to fixation on a Leica dissection microscope. Using the ImageJ freeware, 
cross-sectional area was directly measured by tracing the margins of the kidney, excluding 
the ureter. To quantify tip number, kidneys expressing the Hoxb7-mVenus transgene were 
examined under an epifluorescence microscope directly after dissection, prior to fixation. 
Kidneys from non-transgenic embryos were treated in a whole-mount immunochemistry 
protocol against Calbindin. After overnight fixation in 4% paraformaldehyde in PBS, 
kidneys were washed several times with PBS, pre-blocked in 2% normal donkey serum in 
PBT, and treated overnight with a monoclonal antibody to calbindin (Santa Cruz). A Cy2 
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conjugated secondary antibody (Jackson ImmunoResearch) was applied overnight at 4˚C 
after several rounds of washing with PBS. Tip number was then counted directly under the 
microscope, as with kidneys expressing the transgene, where the three-dimensional organ 
could be rotated and examined thoroughly. 
In situ hybridization
 Whole-mount in situ hybridization to visualize expression of Ret and CRLF1 
mRNA was performed as described (Rumballe et al., 2012). Freshly dissected embryonic 
kidneys were fixed overnight at 4˚C in 4% paraformaldehyde in PBS. After washing 
several times in PBS, the intact kidneys were dehydrated through an ethanol series. In 
vitro transcription was used to synthesize digoxygenin-labeled riboprobes from linearized 
plasmids containing the cDNA. A full-length probe for the Ret9 isoform was used to 
visualize Ret expression. Following hybridiztion, kidneys were treated with a monoclonal 
antibody against digoxygenin conjugated to alkaline-phosphatase (Roche). The substrates 
BCIP and NBT were added to detect alkaline-phosphatase activity. Even though kidneys 
were kept in separate wells to keep genotypes sorted, the incubation periods with BCIP 
and NBT were kept constant across all samples treated with the same probe to provide a 
qualitative readout of relative mRNA levels across samples. 
Analysis of MADM recombinants
 The genetic crosses required to obtain informative MADM recombinants are 
described in detail in Chapter 4. Kidneys were dissected from embryos at P0 - P2 and were 
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fixed overnight in 4% paraformaldehyde at 4˚C. After several PBS washes, kidneys were 
embedded in 3% agarose in PBS and vibratome sectioned at 100 µm intervals. Care was 
taken to mount sections in consecutive order to facilitate the tracing of presumptive clones 
that extended across multiple sections, such as that illustrated in Figure 4.6. Images used 
for the quantitative assesments described in the text were obtained by constructing mosaic 
composites on an inverted Zeiss AxioObserver epifluorescence microscope. 
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